0001140361-23-007348 | 10-K | XBRL Viewer

Print Document View Excel Document

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Dec. 31, 2022	Jan. 31, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Document Transition Report	false
Entity File Number	001-12421
Entity Registrant Name	NU SKIN ENTERPRISES, INC.
Entity Central Index Key	0001021561
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-0565309
Entity Address, Address Line One	75 West Center Street
Entity Address, City or Town	Provo
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84601
City Area Code	801
Local Phone Number	345-1000
Title of 12(b) Security	Class A Common Stock, $.001 par value
Trading Symbol	NUS
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 2,170
Entity Common Stock, Shares Outstanding		49,460,121
Auditor Firm ID	238
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	Salt Lake City, Utah

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 264,725	$ 339,593
Current investments	13,784	15,221
Accounts receivable, net	47,360	41,299
Inventories, net	346,183	399,931
Prepaid expenses and other	87,816	76,906
Total current assets	759,868	872,950
Property and equipment, net	444,806	453,674
Operating lease right-of-use assets	98,734	120,973
Goodwill	206,432	206,432
Other intangible assets, net	66,701	76,991
Other assets	244,429	175,460
Total assets	1,820,970	1,906,480
Current liabilities
Accounts payable	53,963	49,993
Accrued expenses	280,280	372,201
Current portion of long-term debt	25,000	107,500
Total current liabilities	359,243	529,694
Operating lease liabilities	76,540	88,759
Long-term debt	377,466	268,781
Other liabilities	110,425	106,474
Total liabilities	923,674	993,708
Commitments and contingencies (Notes 7 and 16)
Stockholders' equity
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	613,278	601,703
Treasury stock, at cost - 41.1 million and 40.7 million shares	(1,569,061)	(1,526,860)
Accumulated other comprehensive loss	(86,509)	(73,896)
Retained earnings	1,939,497	1,911,734
Total stockholders' equity	897,296	912,772
Total liabilities and stockholders' equity	$ 1,820,970	$ 1,906,480

Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Millions	Dec. 31, 2022	Dec. 31, 2021
Stockholders' equity:
Common stock, shares authorized (in shares)	500.0	500.0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued (in shares)	90.6	90.6
Treasury stock (in shares)	41.1	40.7

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Consolidated Statements of Income [Abstract]
Revenue	$ 2,225,659	$ 2,695,669	$ 2,581,934
Cost of sales	630,915	675,223	658,028
Gross profit	1,594,744	2,020,446	1,923,906
Operating expenses:
Selling expenses	879,634	1,080,153	1,029,869
General and administrative expenses	555,769	654,431	636,473
Restructuring and impairment expenses	48,494	51,870	0
Total operating expenses	1,483,897	1,786,454	1,666,342
Operating income	110,847	233,992	257,564
Other income (expense), net (Note 17)	(21,877)	(1,533)	(1,332)
Income before provision for income taxes	88,970	232,459	256,232
Provision (benefit) for income taxes	(15,808)	85,193	64,877
Net income	$ 104,778	$ 147,266	$ 191,355
Net income per share:
Basic (in dollars per share)	$ 2.1	$ 2.93	$ 3.66
Diluted (in dollars per share)	$ 2.07	$ 2.86	$ 3.63
Weighted-average common shares outstanding:
Basic (in shares)	50,002	50,193	52,296
Diluted (in shares)	50,525	51,427	52,765

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 104,778	$ 147,266	$ 191,355
Other comprehensive income (loss):
Foreign currency translation adjustment, net of taxes of $536, $429, and $(299), respectively	(22,918)	(13,476)	19,708
Net unrealized gains/(losses) on cash flow hedges, net of taxes of $(3,519), $(1,166) and $(220), respectively	12,748	4,225	797
Less: Reclassification adjustment for realized losses/(gains) in current earnings on cash flow hedges, net of taxes of $674, $(34), and $(5), respectively	(2,443)	123	19
Other comprehensive (loss) income, net of tax	(12,613)	(9,128)	20,524
Comprehensive income	$ 92,165	$ 138,138	$ 211,879

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Other comprehensive income (loss):
Foreign currency translation adjustment, tax	$ 536	$ 429	$ (299)
Net unrealized gains/(losses) on foreign currency cash flow hedges, tax	(3,519)	(1,166)	(220)
Reclassification adjustment for realized losses/(gains) in current earnings on cash flow hedges, tax	$ 674	$ (34)	$ (5)

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member] Class A [Member]	Additional Paid-in Capital [Member]	Treasury Stock, at Cost [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total
Balance at beginning of period at Dec. 31, 2019	$ 91	$ 557,544	$ (1,324,826)	$ (85,292)	$ 1,727,772	$ 875,289
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	191,355	191,355
Other comprehensive income (loss), net of tax	0	0	0	20,524	0	20,524
Repurchase of Class A common stock (Note 8)	0	0	(144,334)	0	0	(144,334)
Exercise of employee stock options/vesting of stock awards	0	(1,803)	7,567	0	0	5,764
Stock-based compensation	0	24,060	0	0	0	24,060
Cash dividends	0	0	0	0	(78,387)	(78,387)
Balance at end of period at Dec. 31, 2020	91	579,801	(1,461,593)	(64,768)	1,840,740	894,271
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	147,266	147,266
Other comprehensive income (loss), net of tax	0	0	0	(9,128)	0	(9,128)
Repurchase of Class A common stock (Note 8)	0	0	(80,420)	0	0	(80,420)
Exercise of employee stock options/vesting of stock awards	0	(1,292)	15,153	0	0	13,861
Stock-based compensation	0	23,194	0	0	0	23,194
Cash dividends	0	0	0	0	(76,272)	(76,272)
Balance at end of period at Dec. 31, 2021	91	601,703	(1,526,860)	(73,896)	1,911,734	912,772
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	104,778	104,778
Other comprehensive income (loss), net of tax	0	0	0	(12,613)	0	(12,613)
Repurchase of Class A common stock (Note 8)	0	0	(70,045)	0	0	(70,045)
Exercise of employee stock options/vesting of stock awards	0	(792)	27,844	0	0	27,052
Stock-based compensation	0	12,367	0	0	0	12,367
Cash dividends	0	0	0	0	(77,015)	(77,015)
Balance at end of period at Dec. 31, 2022	$ 91	$ 613,278	$ (1,569,061)	$ (86,509)	$ 1,939,497	$ 897,296

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 45
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 45
-Paragraph 23
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 105
-SubTopic 10
-Section 65
-Paragraph 6
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 105
-SubTopic 10
-Section 65
-Paragraph 6
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(3)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 45
-Paragraph 5
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (d)(2)
-URI https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 848
-SubTopic 10
-Section 65
-Paragraph 2
-Subparagraph (a)(3)(iii)(03)
-URI https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 17
-URI https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (d)(3)
-URI https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333

Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (f)(1)
-URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900

Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (f)(1)
-URI https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(3)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333

+ Details

Consolidated Statements of Stockholder's Equity (Parenthetical) - shares shares in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Stockholders' Equity [Roll Forward]
Exercise of employee stock options (in shares)	1.2	0.7	0.4

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income	$ 104,778	$ 147,266	$ 191,355
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	72,506	76,320	73,991
Non-cash lease expense	44,518	48,704	46,163
Stock-based compensation	12,367	23,194	24,060
Foreign currency (gains)/losses	8,245	7,056	(287)
Loss on disposal of assets	33	13,026	3,209
Impairment of fixed assets and other intangibles	9,916	31,892	0
Unrealized (gain)/losses on equity investments	0	(18,077)	0
Deferred taxes	(51,626)	5,821	(11,914)
Changes in operating assets and liabilities:
Accounts receivable, net	(11,449)	20,219	(11,207)
Inventories, net	40,314	(95,320)	(31,137)
Prepaid expenses and other	2,758	15,132	(153)
Other assets	3,099	(19,792)	(31,616)
Accounts payable	9,263	(13,279)	24,836
Accrued expenses	(120,833)	(104,992)	87,452
Other liabilities	(15,827)	4,412	14,389
Net cash provided by operating activities	108,062	141,582	379,141
Cash flows from investing activities:
Purchases of property and equipment	(59,056)	(68,615)	(63,823)
Proceeds on investment sales	5,932	15,094	14,037
Purchases of investments	(13,955)	(16,242)	(14,693)
Acquisitions (net of cash acquired)	0	(18,963)	(14,949)
Net cash used in investing activities	(67,079)	(88,726)	(79,428)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards	27,052	13,861	5,764
Payment of cash dividends	(77,015)	(76,272)	(78,387)
Repurchase of shares of common stock	(70,045)	(80,420)	(144,334)
Finance lease principal payments	(1,919)	(1,871)	(709)
Payment of debt issuance cost	(5,077)	0	0
Payments on debt	(432,500)	(115,000)	(142,500)
Proceeds from debt	460,000	155,000	115,000
Net cash used in financing activities	(99,504)	(104,702)	(245,166)
Effect of exchange rate changes on cash	(16,347)	(11,244)	12,506
Net increase (decrease) in cash and cash equivalents	(74,868)	(63,090)	67,053
Cash and cash equivalents, beginning of period	339,593	402,683	335,630
Cash and cash equivalents, end of period	$ 264,725	$ 339,593	$ 402,683

The Company

12 Months Ended

Dec. 31, 2022

The Company [Abstract]

The Company

1.	The Company

Nu Skin Enterprises, Inc. (the “Company”) is a holding company, with Nu Skin being the primary operating unit. Nu Skin develops and distributes premium-quality, innovative beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands and a small number of other products and services. The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments—Americas, which includes Canada, Latin America and the United States; Mainland China; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand, and other markets; South Korea; Japan; Europe, Middle East and Africa (“EMEA”), which includes markets in Europe as well as Israel and South Africa; and Hong Kong/Taiwan, which also includes Macau—and two Rhyz Investments segments—Manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz other, which includes other investments by its Rhyz strategic investment arm (the Company’s subsidiaries operating within each segment are collectively referred to as the “Subsidiaries”).

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2022

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2.	Summary of Significant Accounting Policies

Consolidation

The consolidated financial statements include the accounts of the Company and the Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Use of estimates

The preparation of these financial statements, in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), required management to make estimates and assumptions that affected the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results may differ from these estimates.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current presentation. The Company reclassified $12.0 million and $10.4 million of events and other miscellaneous selling costs from the general and administration expenses line to the selling expenses line on the consolidated statement of income for the years ended December 31, 2021 and 2020, respectively. The Company believes these costs are better reflected in selling expenses. The reclassification had no impact on operating income for the years ended December 31, 2021 and 2020.

Cash and cash equivalents

Cash equivalents are short-term, highly liquid instruments with original maturities of 90 days or less.

Accounts receivable

Accounts receivable represents amounts owed to us through our operating activities and are presented net of allowance for doubtful accounts. Accounts receivable for core Nu Skin consists primarily of credit card receivables, while accounts receivable for our Rhyz investments consists primarily of trade receivables from customer sales. For the Company’s trade receivables from its Rhyz investment customers, the Company performs ongoing credit evaluations of its customers and maintains an allowance for expected credit losses. The allowance for expected credit losses represents the Company’s best estimate based on current and historical information, and reasonable and supportable forecasts of future events and circumstances.

Inventories

Inventories consist primarily of merchandise purchased for resale and are stated at the lower of standard cost or net realizable value, using a standard cost method which approximates the first-in, first-out method. The Company had reserves of its inventory carrying value totaling $37.3 million and $18.6 million as of December 31, 2022 and 2021, respectively.

Inventories consist of the following (U.S. dollars in thousands):

	December 31,
	2022		2021
Raw materials	$	163,797	$	179,891
Finished goods		182,386		220,040
Total inventory, net	$	346,183	$	399,931

Reserves of inventories consist of the following (U.S. dollars in thousands):

	2022			2021			2020
Beginning balance	$	18,643		$	14,249		$	12,295
Additions		43,286			31,300			15,952
Write-offs		(24,662	)		(26,906	)		(13,998	)
Ending balance	$	37,267		$	18,643		$	14,249

Prepaid expense and other

Prepaid expenses and other consist of the following (U.S. dollars in thousands):

	December 31,
	2022		2021
Deferred charges	$	11,748	$	14,266
Prepaid income tax		9,333		2,784
Prepaid inventory and import costs		3,540		6,087
Prepaid rent, insurance and other occupancy costs		5,830		3,690
Prepaid promotion and event cost		2,395		4,382
Prepaid other taxes		8,768		9,333
Derivative financial instruments		9,156		557
Prepaid software license		17,463		17,041
Deposits		1,153		1,158
Other		18,430		17,608
Total prepaid expense and other	$	87,816	$	76,906

Property and equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation is recorded using the straight-line method over the following estimated useful lives:

Buildings	39 years
Furniture and fixtures	5 - 7 years
Computers and equipment	3 - 5 years
Leasehold improvements	Shorter of estimated useful life or lease term
Scanners	3 years
Vehicles	3 - 5 years

Expenditures for maintenance and repairs are charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the statement of income. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.

Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, accrued expenses and operating lease liabilities on the consolidated balance sheets. Finance leases are included in other assets, accrued expenses and other liabilities on the consolidated balance sheets.

Operating lease ROU assets represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU assets also include any lease payments made and exclude lease incentives and initial direct costs incurred. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company’s lease agreements do not contain any residual value guarantees.

The Company has lease agreements with lease and non-lease components. The Company accounts for the lease and non-lease components as a single lease component.

Goodwill and other intangible assets

Goodwill is recorded when the cost of acquired businesses exceeds the fair value of the identifiable net assets acquired. Goodwill and intangible assets with indefinite useful lives are not amortized, but are assessed for impairment annually on October 1. In addition, impairment testing is conducted when events occur or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Goodwill and intangible assets with indefinite useful lives would be written down to fair value if considered impaired. Guidance under Accounting Standards Codification (“ASC”) 350, Intangibles - Goodwill and Other (“ASC 350”), requires an entity to test goodwill for impairment on at least an annual basis. The Company had the option to perform a qualitative assessment to determine whether further impairment testing is necessary or to perform a quantitative assessment by comparing the fair value of a reporting unit to its carrying amount, including goodwill. Under the qualitative assessment, an entity is not required to calculate the fair value of a reporting unit unless the entity determines that it is more likely than not that its fair value is less than its carrying amount. If under the quantitative assessment the fair value of a reporting unit is less than its carrying amount, then the amount of the impairment loss, if any, must be measured. In fiscal years 2022 and 2020, a quantitative assessment was performed. The Company elected to perform the qualitative assessment during fiscal year 2021, and determined that it is not more likely than not the carrying value exceeds the fair value of the reporting units. Intangible assets with finite useful lives are amortized to their estimated residual values over such finite lives using the straight-line method and reviewed for impairment whenever events or circumstances warrant such a review.

The Company has historically evaluated its goodwill for impairment annually as of June 30 or more frequently if impairment indicators arose in accordance with ASC 350, “Intangibles - Goodwill and Other.” In the fourth quarter of 2021, the Company changed the date of its annual assessment of goodwill to October 1 for all reporting units. The change in testing date for goodwill is a change in accounting principle, which management believes is preferable as the new date of the assessment better aligns with the Company’s budgeting process and will create a more efficient and timely process surrounding the impairment tests. The change in the assessment date does not delay, accelerate or avoid a potential impairment charge. The Company has determined that it is impracticable to objectively determine projected cash flows and related valuation estimates that would have been used as of each October 1 of prior reporting periods without the use of hindsight. As such, the Company prospectively applied the change in annual goodwill impairment testing date from October 1, 2021. No impairment was recognized during the years ended December 31, 2022 and 2020.

As discussed further in Note 20 of the Notes to Consolidated Financial Statements, during the fourth quarter of fiscal year 2021, the Company recognized an $18.2 million goodwill and intangibles impairment charge related to the Grow Tech segment, which was included in Restructuring and impairment expenses in the consolidated statement of income. During fiscal year 2022, the Company recorded a $1.7 million impairment of other intangibles.

The Company completed the annual goodwill and indefinite-lived intangible asset impairment testing as of October 1, 2022, and concluded that the fair value of the reporting units were determined to be in excess of its carrying amounts and no goodwill impairment charge was required. As of the October 1, 2022 testing date, the fair value of the Manufacturing reporting unit was estimated to be approximately 8% in excess of its carrying amount, and therefore the reporting unit is considered to be at risk of future impairment. The Manufacturing reporting unit’s fair value remains sensitive to significant unfavorable changes in revenue, gross margin and discount rates that could negatively impact future analyses.

Fair value determinations require considerable judgment and are sensitive to changes in underlying assumptions and factors. As a result, there can be no assurance that the estimates and assumptions made for purposes of the goodwill impairment tests will prove to be an accurate prediction of the future. Although the Manufacturing reporting unit showed strong revenue growth in fiscal year 2020 and 2021, the fair value of the reporting unit in the current year was negatively impacted by an increase in the discount rate due to the current interest rate environment, and lower near-term revenue projections. Current projections used for the Manufacturing reporting unit reflect revenue growth attributable to the continued expansion of capacity, continued intercompany sales to Nu Skin, and the recent acquisition of new customers. While historical performance and current expectations have resulted in fair values of the Manufacturing reporting unit in excess of carrying values, if the assumptions are not realized an impairment charge may be recorded in the future.

Equity investments

The Company holds strategic investments in other companies. These investments are accounted for under the measurement alternative described in ASC 321, Investments - Equity Securities (“ASC 321”) for equity investments that do not have readily determinable fair values. These investments are measured at cost, less impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. The Company does not exercise significant influence over these companies. These investments are carried on the consolidated balance sheets within Other Assets. Changes in fair value based on impairments or resulting from observable price changes are recorded in Other Income (expense), net on the consolidated statements of income. See Note 10 – Fair Value and Equity Investments, for further details around the Company’s equity investments.

Other assets

Other assets consist of the following (U.S. dollars in thousands):

	December 31,
	2022		2021
Deferred taxes	$	89,770	$	26,483
Deposits for noncancelable operating leases		13,872		17,121
Cash surrender value for life insurance policies		40,055		49,851
Right-of-use assets, Financing, net		14,259		6,477
Derivative financial instruments		10,582		6,033
Long-term investments		39,493		35,868
Other		36,398		33,627
Total other assets	$	244,429	$	175,460

Accrued expenses

Accrued expenses consist of the following (U.S. dollars in thousands):

	December 31,
	2022		2021
Accrued sales force commissions and other payments	$	95,686	$	139,793
Accrued other taxes		21,822		31,135
Accrued payroll and other employee expenses		37,650		53,641
Accrued payable to vendors		29,569		45,347
Short-term operating lease liability		29,376		33,427
Accrued royalties		845		1,095
Sales return reserve		3,359		3,513
Deferred revenue		27,053		33,139
Other		34,920		31,111
Total accrued expenses	$	280,280	$	372,201

Other liabilities

Other liabilities consist of the following (U.S. dollars in thousands):

	December 31,
	2022		2021
Deferred tax liabilities	$	439	$	2,385
Reserve for other tax liabilities		35,532		21,774
Liability for deferred compensation plan		44,427		54,213
Contingent consideration		6,364		10,341
Finance lease liabilities		12,140		5,318
Asset retirement obligation		5,978		5,408
Other		5,545		7,035
Total other liabilities	$	110,425	$	106,474

Revenue recognition

Net sales include products and shipping and handling charges, net of estimates for product returns and any related sales incentives. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. The Company recognizes revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The Company recognizes revenue for shipping and handling charges at the time the products are delivered to or picked up by the customer. A reserve for product returns is accrued based on historical experience totaling $3.4 million and $3.5 million as of December 31, 2022 and 2021, respectively. During the years ended December 31, 2022, 2021 and 2020, the Company recorded sales returns of $31.6 million, $52.1 million and $49.5 million, respectively. The majority of the Company’s contracts have a single performance obligation and are short term in nature. Sales taxes and value added taxes in foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales.

Contract Liabilities – Customer Loyalty Programs

Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products.

The balance of deferred revenue related to contract liabilities was $18.7 million and $22.0 million as of December 31, 2022, and 2021, respectively. The contract liabilities impact to revenue for the years ended December 31, 2022, 2021 and 2020 was an increase of $3.3 million, decrease of $3.8 million and a decrease of $5.7 million, respectively.

Disaggregation of Revenue

Please refer to Note 15 - Segment Information for revenue by segment and product line.

Arrangements with Multiple Performance Obligations

The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the Company allocates revenues to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the prices charged to customers for individual products sales to customers.

Shipping and handling costs

Shipping and handling costs are recorded as cost of sales and are expensed as incurred.

Advertising expenses

Advertising costs are expensed as incurred and are included in general and administrative expenses in the accompanying consolidated statements of income. Advertising expense incurred for the years ended December 31, 2022, 2021 and 2020 totaled $14.5 million, $15.5 million and $14.7 million, respectively.

Selling expenses

Selling expenses are the Company’s most significant expense and are classified as operating expenses. Selling expenses include commissions the Company pays to its Brand Affiliates, as well as salaries, service fees, benefits, bonuses and other labor and unemployment expenses the Company pays to its sales force in Mainland China. Selling expenses do not include amounts the Company pays to its sales force based on their personal purchases; rather, such amounts are reflected as reductions to revenue. The term “Brand Affiliates” refers to members of the Company’s independent sales force in all of the Company’s markets besides Mainland China. In each of the Company’s markets, except Mainland China, Sales Leaders can earn “multi-level” compensation under the Company’s global sales compensation plan, including commissions for product sales to their consumer groups as well as the product sales made through the sales network they have developed and trained. The Company does not pay commissions on sales materials.

Outside of Mainland China, the Company’s Brand Affiliates may make profits by purchasing the products from the Company at a discount and selling them to consumers with a mark-up. The Company does not account for nor pay additional commissions on these mark-ups received by Brand Affiliates. In many markets, the Company also allows individuals who are not members of its sales force, referred to as “preferred customers,” to buy products directly from the Company at a discount. The Company pays commissions on preferred customer purchases to the referring member of its sales force.

Research and development

Research and development costs are expensed as incurred and are included in general and administrative expenses in the accompanying consolidated statements of income and totaled $23.3 million, $27.2 million and $23.3 million in 2022, 2021 and 2020, respectively.

Deferred tax assets and liabilities

The Company accounts for income taxes in accordance with the Income Taxes Topic of the Financial Accounting Standards Codification. These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise’s activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. These deferred tax assets assume sufficient future earnings will exist for their realization, and are calculated using anticipated tax rates. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.

Uncertain tax positions

The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. In 2009, we entered into a voluntary program with the IRS called Compliance Assurance Process (“CAP”). Under the CAP program, the IRS audits the tax position of the Company to identify and resolve any tax issues that may arise throughout the tax year. As of December 31, 2022, tax years through 2020 have been audited and are effectively closed to further examination. For tax years 2021 and 2022, the Company is in the Bridge phase of the CAP program, pursuant to which the IRS will not accept disclosures, will not conduct reviews and will not provide letters of assurance for the year. There are limited circumstances that tax years in the Bridge phase will be opened for examination. The company has applied for the CAP program for tax year 2023 and is currently waiting on approval from the IRS. With a few exceptions, we are no longer subject to state and local income tax examination by tax authorities for the years before 2019. Foreign jurisdictions have varying lengths of statutes of limitations for income tax examinations. Some statutes are as short as three years and in certain markets may be as long as ten years. The Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable.

A reconciliation of the beginning and ending amount of unrecognized tax benefits included in other liabilities is as follows (U.S. dollars in thousands):

	2022			2021			2020
Gross balance at January 1	$	15,090		$	17,620		$	13,507
Increases related to prior year tax positions		6,768			4,146			2,958
Increases related to current year tax positions		5,485			1,794			3,302
Settlements		(2,590	)		(5,494	)		(1,091	)
Decreases due to lapse of statutes of limitations		(95	)		(2,409	)		(1,377	)
Currency adjustments		(1,559	)		(567	)		321
Gross balance at December 31	$	23,099		$	15,090		$	17,620

At December 31, 2022, the Company had $23.1 million in unrecognized tax benefits of which $23.1 million, if recognized, would affect the effective tax rate. In comparison, at December 31, 2021, the Company had $15.1 million in unrecognized tax benefits of which $15.1 million, if recognized, would affect the effective tax rate. The Company’s unrecognized tax benefits relate to multiple foreign and domestic jurisdictions. Due to potential changes in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitation, it is reasonably possible that the Company’s gross unrecognized tax benefits, net of foreign currency adjustments, may increase within the next 12 months by a range of approximately $2.0 to $3.0 million.

During the years ended December 31, 2022, 2021 and 2020 the Company recognized $5.7 million, $1.6 million and $1.5 million, respectively in interest and penalties expenses related to uncertain tax positions. The Company had $12.4 million, $6.7 million and $5.1 million of accrued interest and penalties related to uncertain tax positions at December 31, 2022, 2021 and 2020, respectively. Interest and penalties related to uncertain tax positions are recognized as a component of income tax expense.

Net income per share

Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented (Note 8).

Foreign currency translation

A significant portion of the Company’s business operations occurs outside of the United States. The local currency of each of the Company’s Subsidiaries is considered its functional currency, except for the Company’s subsidiaries in Singapore and countries deemed highly inflationary where the U.S. dollar is used. All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders’ equity is recorded at historical exchange rates. The resulting foreign currency translation adjustments are recorded as a separate component of stockholders’ equity in the consolidated balance sheets and transaction gains and losses are included in other income (expense) in the consolidated statements of income. Net of tax, the accumulated other comprehensive loss related to the foreign currency translation adjustments are $102.0 million (net of tax of $8.1 million), $79.1 million (net of tax of $7.5 million), and $65.6 million (net of tax of $7.1 million), at December 31, 2022, 2021 and 2020, respectively.

Classification of a highly inflationary economy

A market is considered to have a highly inflationary economy if it has a cumulative inflation rate of approximately 100% or more over a three-year period as well as other qualitative factors including historic inflation rate trends (increasing and decreasing), the capital intensiveness of the operation and other pertinent economic factors. The functional currency in highly inflationary economies is required to be the functional currency of the entity’s parent company, and transactions denominated in the local currency are remeasured to the functional currency. The remeasurement of local currency into U.S. dollars creates foreign currency transaction gains or losses, which the Company includes in its consolidated statements of income.

In the second quarter of 2018, published inflation indices indicated that the three-year cumulative inflation in Argentina exceeded 100 percent, and as of July 1, 2018, we elected to adopt highly inflationary accounting for our subsidiary in Argentina. Under highly inflationary accounting, Argentina’s functional currency became the U.S. dollar, and its income statement and balance sheet have been measured in U.S. dollars using both current and historical rates of exchange. The effect of changes in exchange rates on peso-denominated monetary assets and liabilities has been reflected in earnings in Other income (expense), net and was not material. As of December 31, 2022, and 2021, Argentina had a small net peso monetary position. Net sales of Argentina were less than 2 percent of our consolidated net sales for the years ended December 31, 2022, 2021 and 2020.

Fair value of financial instruments

The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate fair values due to the short-term nature of these instruments. The Company’s current investments as of December 31, 2022 include certificates of deposits and pre-refunded municipal bonds that are classified by management as held-to-maturity as the Company had the positive intent and ability to hold to maturity. The carrying value of these current investments approximate fair values due to the short-term nature of these instruments. As of December 31, 2022 and 2021, the fair value of debt was $405.0 million and $377.5 million, respectively. The estimated fair value of the Company’s debt is based on interest rates available for debt with similar terms and remaining maturities.

The FASB Codification defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. On a quarterly basis, the Company measures at fair value certain financial assets, including cash equivalents. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy:

●

Level 1 – quoted prices in active markets for identical assets or liabilities;

●

Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;

●

Level 3 – unobservable inputs based on the Company’s own assumptions.

Accounting standards permit companies, at their option, to measure many financial instruments and certain other items at fair value. The Company has elected not to apply the fair value option to existing eligible items.

Stock-based compensation

All share-based payments, including grants of stock options and restricted stock units, are required to be recognized in the Company’s financial statements based upon their respective grant date fair values. The Black-Scholes option-pricing model is used to estimate the fair value of stock options. The determination of the fair value of stock options is affected by the Company’s stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical volatility as the expected volatility assumption required in the Black-Scholes model. The expected life of the stock options is based on historical data trended into the future. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the Company’s stock options. The fair value of the Company’s restricted stock units is based on the closing market price of its stock on the date of grant less the Company’s expected dividend yield. The Company recognizes stock-based compensation net of actual forfeitures over the requisite service period of the award.

The total compensation expense related to equity compensation plans was $12.4 million, $23.2 million and $24.1 million for the years ended December 31, 2022, 2021 and 2020, respectively. In 2022, 2021 and 2020, these amounts reflect the reversal of $1.3, none, and none, respectively, for certain performance-based awards that were no longer expected to vest. For the years ended December 31, 2022, 2021 and 2020, all stock-based compensation expense was recorded within general and administrative expenses.

Reporting comprehensive income

Comprehensive income is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources, and it includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Derivative instruments and hedging activities

FASB ASC 815, Derivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how the entity accounts for derivative instruments and related hedged items, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments.

As required by ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.

In accordance with the FASB’s fair value measurement guidance in ASU 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.

Recent accounting pronouncements

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance for a limited time to ease the potential burden in accounting for the effects of reference rate reform on financial reporting. The guidance provides optional expedients and exceptions for applying US GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ASU 2020-04 applies only to contracts and hedging relationships that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued due to reference rate reform. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2024. The amendments in ASU 2020-04 are elective and are effective upon issuance for all entities. The Company had previously elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. In the second quarter of 2022, the Company elected the hedge accounting expedient that allows an update to the hedged risk in active hedging relationships without de-designation as the Company’s debt transitioned to SOFR. In the fourth quarter of 2022, the Company elected the hedge accounting expedient that allows an amendment to existing hedges without de-designation as the Company’s hedges transitioned to SOFR. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.

Property and Equipment

12 Months Ended

Dec. 31, 2022

Property and Equipment [Abstract]

Property and Equipment

3.	Property and Equipment

Property and equipment are comprised of the following (U.S. dollars in thousands):

	December 31,
	2022			2021
Land	$	42,931		$	45,027
Buildings		274,049			281,192
Construction in progress⁽¹⁾		64,566			44,021
Furniture and fixtures		136,835			147,786
Computers and equipment		145,934			162,746
Leasehold improvements		114,633			129,675
Scanners		6,438			6,746
Vehicles		1,606			2,021
		786,992			819,214
Less: accumulated depreciation		(342,186	)		(365,540	)
	$	444,806		$	453,674

(1)	Construction in progress includes $20.5 million and $11.0 million as of December 31, 2022 and 2021, respectively, of eligible capitalized internal-use software development costs which will be reclassified to computers and equipment when placed into service.

Depreciation of property and equipment totaled $61.0 million, $62.9 million and $62.5 million for the years ended December 31, 2022, 2021 and 2020, respectively. The Company recorded impairments of $8.2 million and $13.7 million for the years ended December 31, 2022 and 2021, respectively, in connection with our fiscal year 2022 and 2021 restructuring plans, see Note 20 – Restructuring and Severance Charges.

Goodwill

12 Months Ended

Dec. 31, 2022

Goodwill [Abstract]

Goodwill

The following table presents goodwill allocated to the Company’s reportable segments for the periods ended December 31, 2022 and 2021 (U.S. dollars in thousands):

	December 31,
	2022		2021
Nu Skin
Americas	$	9,449	$	9,449
Mainland China		32,179		32,179
Southeast Asia/Pacific		18,537		18,537
South Korea		29,261		29,261
Japan		16,019		16,019
EMEA		2,875		2,875
Hong Kong/Taiwan		6,634		6,634
Rhyz Investments
Manufacturing		78,875		78,875
Rhyz Other		12,603		12,603
Total	$	206,432	$	206,432

All of the Company’s goodwill is recorded in U.S. dollar functional currency and allocated to the respective segments. Goodwill is not amortized; rather, it is subject to annual impairment tests. In connection with the Company’s decision to exit the Grow Tech segment, a $9.2 million impairment charge was recorded in the year ended December 31, 2021, see Note 20 for further discussion regarding the restructuring and impairment of the Grow Tech segment.

Other Intangible Assets

12 Months Ended

Dec. 31, 2022

Other Intangible Assets [Abstract]

Other Intangible Assets

5.	Other Intangible Assets

Other intangible assets consist of the following (U.S. dollars in thousands):

	Carrying Amount at December 31,
	2022		2021
Indefinite life intangible assets:
Trademarks and trade names	$	24,599	$	24,599

	December 31, 2022				December 31, 2021
Finite life intangible assets:	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization		Weighted- average Amortization Period
Scanner technology	$	40,716	$	40,716	$	40,716	$	40,716	18 years
Developed technology		43,841		27,365		43,841		24,697	14 years
Sales force network		11,598		11,598		11,598		11,598	15 years
Trademarks		7,860		4,200		8,989		3,827	9 years
Other		48,285		26,319		51,176		23,090	8 years
	$	152,300	$	110,198	$	156,320	$	103,928	13 years

Amortization of finite-life intangible assets totaled $9.7 million, $11.7 million and $9.8 million for the years ended December 31, 2022, 2021 and 2020, respectively.

The estimated annual amortization expense for each of the five succeeding fiscal years are as follows (U.S. dollars in thousands):

Year Ending December 31,
2023	$	9,595
2024		9,108
2025		7,826
2026		6,222
2027		4,373

Indefinite life intangible assets are not amortized, rather they are subject to annual impairment tests. Finite life intangibles are amortized over their useful lives unless circumstances occur that cause the Company to revise such lives or review such assets for impairment. In connection with the Company’s decision to exit the Grow Tech segment, a $3.8 million impairment charge related to other indefinite lived intangibles and a $5.2 million impairment charge related to other finite lived intangibles was recorded in the year ended December 31, 2021, see Note 20 for further discussion restructuring and impairment of the Grow Tech segment. During 2022, the Company recorded a $1.7 million impairment charge for other intangibles associated with our 2022 restructuring, see Note 20 for further discussion.

Long-Term Debt

12 Months Ended

Dec. 31, 2022

Long-Term Debt [Abstract]

Long-Term Debt

6.	Long-Term Debt

2018 Credit Agreement

On April 18, 2018, the Company entered into a Credit Agreement (the “2018 Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent. The 2018 Credit Agreement provided for a $400 million term loan facility and a $350 million revolving credit facility, each with a term of five years. Both facilities bore interest at the LIBOR, plus a margin based on the consolidated leverage ratio. The term loan facility amortized in quarterly installments in amounts resulting in an annual amortization of 5.0% during the first and second years, 7.5% during the third and fourth years and 10.0% during the fifth year after the closing date of the 2018 Credit Agreement, with the remainder payable at final maturity. The 2018 Credit Agreement required the Company to maintain a consolidated leverage ratio not exceeding 2.25 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00.

Credit Agreement

On June 14, 2022, the Company entered into an Amended and Restated Credit Agreement (the “Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent, which amended and restated the 2018 Credit Agreement. The Credit Agreement provides for a $400 million term loan facility and a $500 million revolving credit facility, each with a term of five years. Both facilities bear interest at the SOFR, plus a margin based on the Company’s consolidated leverage ratio. Commitment fees payable under the Credit Agreement are also based on the consolidated leverage ratio as defined in the Credit Agreement and range from 0.175% to 0.30% on the unused portion of the total lender commitments then in effect. The term loan facility amortizes in quarterly installments in amounts resulting in an annual amortization of 2.5% during the first year and 5.0% during the second, third, fourth and fifth years after the closing date of the Credit Agreement, with the remainder payable at final maturity. The Credit Agreement is guaranteed by certain of the Company’s domestic subsidiaries and collateralized by assets of such subsidiaries, including a pledge of 65% of the capital stock of certain foreign subsidiaries. The Credit Agreement requires the Company to maintain a consolidated leverage ratio not exceeding 2.75 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. As of December 31, 2022, the Company was in compliance with all covenants under the Credit Agreement.

The following table summarizes the Company’s debt facilities as of December 31, 2022 and 2021:

Facility or Arrangement	Original Principal Amount	Balance as of December 31, 2022 ⁽¹⁾⁽²⁾	Balance as of December 31, 2021 ⁽¹⁾⁽²⁾	Interest Rate	Repayment Terms
2018 Credit Agreement term loan facility	$400.0 million	—	$307.5 million		Principal amount was paid in full during June 2022.

2018 Credit Agreement revolving credit facility		—	$70.0 million		Principal amount was paid in full during June 2022 and credit line was closed.

Credit Agreement term loan facility	$400.0 million	$395.0 million	—	Variable 30 day: 6.17%	21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term.

Credit Agreement revolving credit facility		$10.0 million	—	Variable 30 day: 6.17%	Revolving line of credit expires June 14, 2027.

(1)	As of December 31, 2022 and 2021, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $15.0 million and $37.5 million, respectively, of the balance of its term loan under the Credit Agreement and 2018 Credit Agreement.

(2)	The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.5 million and $1.2 million as of December 31, 2022 and 2021, respectively, related to the Credit Agreement and 2018 Credit Agreement, which are not reflected in this table.

Maturities of all long-term debt at December 31, 2022, are as follows (U.S. dollars in thousands):

Year Ending December 31,
2023	$	15,000
2024		20,000
2025		20,000
2026		20,000
2027		320,000
Thereafter		—
Total ⁽¹⁾	$	395,000

(1)	The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $2.5 million, which is not reflected in this table.

Leases

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Leases

The Company has operating and finance leases for regional offices, manufacturing facilities, retail centers, distribution centers and certain equipment. The Company’s leases have remaining lease terms of 1 year to 22 years, some of which include options to extend the leases for up to 20 years, and some of which include options to terminate the leases within 1 year.

As of December 31, 2022, the weighted average remaining lease term was 8.8 and 4.6 years for operating and finance leases, respectively. As of December 31, 2022, the weighted average discount rate was 3.3% and 3.5% for operating and finance leases, respectively.

The components of lease expense were as follows (U.S. dollars in thousands):

	Year Ended December 31,
	2022		2021			2020
Operating lease expense
Operating lease cost	$	39,682	$	48,447		$	51,828
Variable lease cost		6,061		5,734			4,366
Short-term lease cost		210		592			1,056
Sublease income		—		(5,663	)		(5,052	)
Finance lease expense
Amortization of right-of-use assets		2,371		2,398			1,023
Interest on lease liabilities		268		319			154
Total lease expense	$	48,592	$	51,827		$	53,375

Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands):

	Year Ended December 31,
	2022		2021		2020
Operating cash outflow from operating leases	$	37,174	$	51,570	$	56,395
Operating cash outflow from finance leases	$	243	$	322	$	138
Financing cash outflow from finance leases	$	1,919	$	1,871	$	709
Right-of-use assets obtained in exchange for operating lease obligations	$	34,026	$	25,427	$	82,662
Right-of-use assets obtained in exchange for finance lease obligations	$	9,797	$	74	$	9,206

Maturities of lease liabilities were as follows (U.S. dollars in thousands):

Year Ending December 31,	Operating Leases		Finance Leases
2023	$	26,086	$	3,836
2024		18,808		3,428
2025		13,338		3,371
2026		8,692		3,277
2027		7,690		2,933
Thereafter		42,385		—
Total		116,999		16,845
Less: Finance charges		15,542		1,362
Total principal liability	$	101,457	$	15,483

The Company has additional lease liabilities of $5.5 million which have not yet commenced as of December 31, 2022, and as such, have not been recognized on the consolidated balance sheets.

Capital Stock

12 Months Ended

Dec. 31, 2022

Capital Stock [Abstract]

Capital Stock

8.	Capital Stock

The Company’s authorized capital stock consists of 25 million shares of preferred stock, par value $0.001 per share, 500 million shares of Class A common stock, par value $0.001 per share, and 100 million shares of Class B common stock, par value $0.001 per share. As of December 31, 2022 and 2021, there were no preferred or Class B common shares outstanding. Each share of Class A common stock entitles the holder to one vote on matters submitted to a vote of the Company’s stockholders. Stock dividends of Class A common stock may be paid only to holders of Class A common stock. Class A common stock has no conversion rights.

Weighted-average common shares outstanding

The following is a reconciliation of the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands):

	Year Ended December 31,
	2022		2021		2020
Basic weighted-average common shares outstanding		50,002		50,193		52,296
Effect of dilutive securities:
Stock awards and options		523		1,234		469
Diluted weighted-average common shares outstanding		50,525		51,427		52,765

For the years ended December 31, 2022, 2021 and 2020, other stock options totaling 0.1 million, 0.1 million and 0.4 million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive.

Dividends

Quarterly cash dividends for the years ended December 31, 2022 and 2021 totaled $77.0 million and $76.3 million or $0.385 per share in all quarters of 2022 and $0.38 for all quarters of 2021. The board of directors has declared a quarterly cash dividend of $0.39 per share of Class A common stock to be paid on March 8, 2023 to stockholders of record on February 27, 2023.

Repurchases of common stock

In July 2018, the Company’s board of directors approved a stock repurchase plan with an authorization amount of $500 million. The repurchases are used primarily for strategic initiatives and to offset dilution from the Company’s equity incentive plans. During the years ended December 31, 2022, 2021 and 2020, the Company purchased 1.7 million, 1.6 million and 5.1 million shares under the 2018 plan for $70.0 million, $80.4 million and $144.3 million, respectively. At December 31, 2022, $175.4 million was available for repurchases under the 2018 stock repurchase plan.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

+ Details

Stock-Based Compensation

12 Months Ended

Dec. 31, 2022

Stock-Based Compensation [Abstract]

Stock-Based Compensation

9.	Stock–Based Compensation

At December 31, 2022, the Company had the following stock-based employee compensation plans:

Equity Incentive Plans

In April 2010, the Company’s board of directors approved the Nu Skin Enterprises, Inc. 2010 Omnibus Incentive Plan (the “2010 Omnibus Incentive Plan”). This plan was approved by the Company’s stockholders at the Company’s 2010 Annual Meeting of Stockholders held in May 2010. The 2010 Omnibus Incentive Plan provides for granting of a variety of equity-based awards including stock options, stock appreciation rights, restricted stock, restricted stock units, other share-based awards, performance cash, performance shares and performance units to executives, other employees, independent consultants and directors of the Company and its subsidiaries. Options granted under the 2010 Omnibus Incentive Plan are generally non-qualified stock options, but the 2010 Omnibus Incentive Plan permits some stock options granted to qualify as “incentive stock options” under the U.S. Internal Revenue Code. The exercise price of a stock option generally is equal to the fair market value of the Company’s common stock on the stock option grant date. The contractual term of a stock option granted under the 2010 Omnibus Incentive Plan is seven years. Currently, all shares issued upon the exercise of stock options are from the Company’s treasury shares. Subject to certain adjustments, 7.0 million shares were authorized for issuance under the 2010 Omnibus Incentive Plan. On June 3, 2013, the Company’s stockholders approved an Amended and Restated 2010 Omnibus Incentive Plan, which among other things increased the number of shares available for awards by 3.2 million shares. On May 24, 2016, the Company’s stockholders approved a Second Amended and Restated 2010 Omnibus Incentive Plan, which among other things increased the number of shares available for awards by 3.8 million shares. On June 3, 2020, the Company’s stockholders approved a Third Amended and Restated 2010 Omnibus Incentive Plan, which among other things increased the number of shares available for awards by 5.9 million shares.

The fair value of stock option awards was estimated using the Black-Scholes option-pricing model with the following assumptions and weighted-average fair values as follows:

	December 31,
Stock Options:	2021			2020
Weighted-average grant date fair value of grants	$	16.10		$	8.59
Risk-free interest rate⁽¹⁾		0.5	%		1.4	%
Dividend yield⁽²⁾		2.9	%		2.9	%
Expected volatility⁽³⁾		49.5	%		40.7	%
Expected life in months⁽⁴⁾	56 months			59 months

(1)	The risk-free interest rate is based upon the rate on a zero-coupon U.S. Treasury bill, for periods within the contractual life of the option, in effect at the time of the grant.

(2)	The dividend yield is based on the average of historical stock prices and actual dividends paid.

(3)	Expected volatility is based on the historical volatility of the Company’s stock price, over a period similar to the expected life of the option.

(4)	The expected term of the option is based on the historical employee exercise behavior, the vesting terms of the respective option, and a contractual life of either seven or ten years.

Options under the plans as of December 31, 2022 and changes during the year ended December 31, 2022 were as follows:

	Shares (in thousands)			Weighted- average Exercise Price		Weighted- average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Options activity – service based
Outstanding at December 31, 2021		538.2		$	35.89
Granted		—			—
Exercised		(340.0	)		33.15
Forfeited/cancelled/expired		(34.3	)		54.45
Outstanding at December 31, 2022		163.9			37.69		0.35	$	834
Exercisable at December 31, 2022		163.9			37.69		0.35		834

Options activity – performance based
Outstanding at December 31, 2021		2,220.1		$	40.87
Granted		—			—
Exercised		(340.5	)		31.14
Forfeited/cancelled/expired		(418.0	)		50.66
Outstanding at December 31, 2022		1,461.6			40.30		3.89	$	9,515
Exercisable at December 31, 2022		958.6			39.46		3.41		7,193

Options activity – all options
Outstanding at December 31, 2021		2,758.3		$	39.90
Granted		—			—
Exercised		(680.5	)		31.65
Forfeited/cancelled/expired		(452.3	)		50.95
Outstanding at December 31, 2022		1,625.5			40.04		3.53	$	10,349
Exercisable at December 31, 2022		1,122.5			39.20		2.96		8,027

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the respective years and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2022. This amount varies based on the fair market value of the Company’s stock.

Cash proceeds, tax benefits and intrinsic value related to total stock options exercised during 2022, 2021 and 2020, were as follows (U.S. dollars in thousands):

	December 31,
	2022		2021		2020
Cash proceeds from stock options exercised	$	31,600	$	14,435	$	7,419
Tax benefit / (expense) realized for stock options exercised		229		807		(459	)
Intrinsic value of stock options exercised		15,505		8,402		5,232

Nonvested restricted stock awards as of December 31, 2022 and changes during the year ended December 31, 2022 were as follows:

	Number of Shares (in thousands)			Weighted- average Grant Date Fair Value
Nonvested at December 31, 2021		884.9		$	44.11

Granted		587.1			46.04
Vested		(326.6	)		47.03
Forfeited		(192.4	)		44.01

Nonvested at December 31, 2022		953.0		$	44.28

Nonvested performance share units as of December 31, 2022 and changes during the year ended December 31, 2022 were as follows:

	Number of Shares (in thousands)			Weighted- average Grant Date Fair Value
Nonvested at December 31, 2021		—		$	—

Granted		192.7			44.39
Vested		—			—
Forfeited		(12.5	)		44.39

Nonvested at December 31, 2022		180.2		$	44.39

Stock-based compensation expense is recognized on a straight-line basis, except for performance-based awards for which expense is recognized using a graded-attribution method if the results are materially different than the straight-line method. The Company recognized none, none and $0.3 million of expense related to service condition stock options in 2022, 2021 and 2020, respectively; and recognized $14.3 million, $15.4 million and $13.9 million of expense related to service condition restricted stock units in 2022, 2021 and 2020, respectively. For performance stock options and performance stock units, an expense is recorded each period for the estimated expense associated with the projected achievement of the performance-based targets. The Company recognized $2.0 million of income, $7.8 million of expense and $9.9 million of expense related to performance stock options in 2022, 2021 and 2020, respectively; and no expense related to performance stock units in 2022, 2021 and 2020. The amount in 2022 reflects the reversal of stock compensation for awards no longer expected to vest.

As of December 31, 2022, there was $0.1 million of unrecognized stock-based compensation expense related to nonvested stock option awards. That cost is expected to be recognized over a weighted-average period of 0.1 years. As of December 31, 2022, there was $29.6 million of unrecognized stock-based compensation expense related to nonvested restricted stock awards. That cost is expected to be recognized over a weighted-average period of 2.6 years.

Fair Value and Equity Investments

12 Months Ended

Dec. 31, 2022

Fair Value and Equity Investments [Abstract]

Fair Value and Equity Investments

10.	Fair Value and Equity Investments

Fair Value

The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands):

	Fair Value at December 31, 2022
	Level 1		Level 2		Level 3			Total
Financial assets (liabilities):
Cash equivalents and current investments	$	55,356	$	—	$	—		$	55,356
Derivative financial instruments asset		—		19,738		—			19,738
Life insurance contracts		—		—		40,055			40,055
Contingent consideration		—		—		(6,364	)		(6,364	)
Total	$	55,356	$	19,738		33,691		$	108,785

	Fair Value at December 31, 2021
	Level 1		Level 2		Level 3			Total
Financial assets (liabilities):
Cash equivalents and current investments	$	66,477	$	—	$	—		$	66,477
Derivative financial instruments asset		—		6,590		—			6,590
Life insurance contracts		—		—		49,851			49,851
Contingent consideration		—		—		(10,341	)		(10,341	)
Total	$	66,477	$	6,590	$	39,510		$	112,577

The following methods and assumptions were used to determine the fair value of each class of assets and liabilities recorded at fair value in the consolidated balance sheets:

Cash equivalents and current investments: Cash equivalents and current investments primarily consist of highly rated money market funds with maturities of three months or less, and are purchased daily at par value with specified yield rates. Due to the high ratings and short-term nature of the funds, the Company considers all cash equivalents and current investments as Level 1. Current investments include $4.9 million and $5.2 million as of December 31, 2022 and 2021, respectively, that is restricted for the Company’s voluntary participation in a consumer protection cooperative in South Korea, along with investments in corporate securities.

Life insurance contracts: ASC 820 preserves practicability exceptions to fair value measurements provided by other applicable provisions of U.S. GAAP. The guidance in ASC 715-30-35-60 allows a reporting entity, as a practical expedient, to use cash surrender value or conversion value as an expedient for fair value when it is present. Accordingly, the Company determines the fair value of its life insurance contracts as the cash-surrender value of life insurance policies held in its Rabbi Trust as disclosed in Note 13, “Deferred Compensation Plan.”

Derivative financial instruments asset and liability: Derivative financial instruments are measured at fair value based on observable market information and appropriate valuation methods. See Note 14, “Derivative Financial Instruments” for more information on derivative financial instruments.

Contingent consideration: Contingent consideration represents the obligations incurred in connection with acquisitions. The estimate of fair value of the contingent consideration obligations requires subjective assumptions to be made regarding the future business results, discount rates, discount periods and probabilities assigned to various potential business result scenarios and was determined using probability assessments with respect to the likelihood of reaching various targets or of achieving certain milestones. The fair value measurement is based on significant inputs unobservable in the market and thus represents a level 3 measurement. Changes in current expectations of progress could change the probability of achieving the targets within the measurement periods and result in an increase or decrease in the fair value of the contingent consideration obligation.

The following table provides a summary of changes in fair value of the Company’s Level 3 life insurance contracts (U.S. dollars in thousands):

	2022			2021
Beginning balance at January 1	$	49,851		$	45,453
Actual return on plan assets		(9,180	)		5,153
Purchases and issuances		—			6,261
Sales and settlements		(616	)		(7,016	)
Ending balance at December 31	$	40,055		$	49,851

The following table provides a summary of changes in fair value of the Company’s Level 3 contingent consideration (U.S. dollars in thousands):

	2022			2021
Beginning balance at January 1	$	(10,341	)	$	(3,125	)
Additions from acquisitions		—			(8,702	)
Changes in fair value of contingent consideration		3,977			1,486
Ending balance at December 31	$	(6,364	)	$	(10,341	)

Equity Investments

The Company maintains equity investments in companies which are accounted for under the measurement alternative described in ASC 321-10-35-2 for equity securities that lack readily determinable fair values. The carrying amount of equity securities held by the Company without readily determinable fair values was $28.1 million as of December 31, 2022 and 2021. During the year ended December 31, 2021, the Company made an additional investment of $5.0 million. During the year ended December 31, 2021, the Company recognized $18.1 million of upward fair value adjustments, based on the third quarter of 2021 valuation of additional equity issued by the investee which was deemed to be an observable transaction of a similar investment under ASC 321. The gain was recorded within Other income (expense), net on the consolidated statement of income. The upward fair value adjustment represents a nonrecurring fair value measurement based on observable price changes and is classified as a level 2 fair value measurement.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Income Taxes

12 Months Ended

Dec. 31, 2022

Income Taxes [Abstract]

Income Taxes

11.	Income Taxes

Consolidated income before provision for income taxes consists of the following for the years ended December 31, 2022, 2021 and 2020 (U.S. dollars in thousands):

	2022		2021		2020
U.S.	$	24,411	$	45,371	$	71,138
Foreign		64,559		187,088		185,094
Total	$	88,970	$	232,459	$	256,232

The provision for current and deferred taxes for the years ended December 31, 2022, 2021 and 2020 consists of the following (U.S. dollars in thousands):

	2022			2021			2020
Current
Federal	$	—		$	—		$	—
State		1,515			1,458			1,629
Foreign		34,117			77,393			77,079
		35,632			78,851			78,708
Deferred
Federal		(65,733	)		3,705			(14,430	)
State		(1,239	)		(38	)		(563	)
Foreign		15,532			2,675			1,162
		(51,440	)		6,342			(13,831	)
Provision for income taxes	$	(15,808	)	$	85,193		$	64,877

The principal components of deferred taxes are as follows (U.S. dollars in thousands):

	Year Ended December 31,
	2022			2021
Deferred tax assets:
Inventory differences	$	41,127		$	5,859
Foreign tax credit and other foreign benefits		51,273			69,401
Stock-based compensation		5,981			9,392
Accrued expenses not deductible until paid		37,181			36,401
Foreign currency exchange		—			605
Net operating losses		12,773			9,479
Capitalized research and development		26,406			22,962
R&D credit carryforward		1,795			1,451
Other		242			34
Gross deferred tax assets		176,778			155,584
Deferred tax liabilities:
Foreign currency exchange		3,225			—
Foreign withholding taxes		15,375			15,412
Intangibles step-up		4,446			4,446
Overhead allocation to inventory		3,504			3,373
Amortization of intangibles		21,211			21,936
Other		6,129			6,133
Gross deferred tax liabilities		53,890			51,300
Valuation allowance		(33,557	)		(80,186	)
Deferred taxes, net	$	89,331		$	24,098

At December 31, 2022, the Company had foreign operating loss carryforwards of $35.4 million for tax purposes, which will be available to offset future taxable income. If not used, $18.6 million of carryforwards will expire between 2023 and 2042, while $16.8 million do not expire. A valuation allowance has been placed on foreign operating loss carryforwards of $34.8 million, tax effected the valuation on the net operating loss is $12.7 million. In addition, a valuation allowance of $19.1 million has been recorded on a portion of the foreign tax credit carryforwards which will expire between 2028 and 2031, and all of the R&D credit carryforward of $1.8 million which will expire between 2036 and 2041.

The Company uses the tax law ordering approach when determining when excess tax benefits have been realized.

Valuation allowances have been recognized for a portion of the foreign tax credit, the foreign net operating loss carryforwards, and the R&D credit carryforward. During 2022, the Company made an election to change its capitalization policy for tax purposes related to certain direct and indirect costs for inventory and self-constructed assets under Internal Revenue Code (“IRC”) Section 263A. This method change allows the Company to utilize a portion of its tax attributes related to foreign tax credits in the United States that were previously fully reserved. The impact of the method change is approximately $51.3 million from the utilization of foreign tax credits and the release of valuation allowances. This change only impacts a portion of the Company’s foreign tax credit carryforwards and the Company will maintain a valuation allowance against the remaining balance of foreign tax credit carryforwards. The remaining valuation allowances were recognized for assets which it is more likely than not some portion or all of the deferred tax asset will not be realized. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary difference, projected future taxable income, tax planning strategies and recent financial operations. When the Company determines that there is sufficient positive evidence to utilize the remaining foreign tax credits, the foreign net operating losses, or the R&D credit carryforward, the valuation allowance will be released which would reduce the provision for income taxes.

The deferred tax asset valuation adjustments for the years ended December 31, 2022, 2021 and 2020 are as follows (U.S. dollars in thousands):

	Year Ended December 31,
	2022			2021			2020
Balance at the beginning of period	$	80,186		$	67,340		$	77,042
Additions charged to cost and expenses		3,231	⁽¹⁾		12,674	⁽⁴⁾		2,154	⁽⁶⁾
Decreases		(50,315	)⁽²⁾		—	⁽⁵⁾		(12,100	)⁽⁷⁾
Adjustments		455	⁽³⁾		172	⁽³⁾		244	⁽³⁾
Balance at the end of the period	$	33,557		$	80,186		$	67,340

(1)	Increase in valuation is due primarily to net operating losses in foreign markets.

(2)	The decrease was due to utilization of $18.1 million of foreign tax credits and the valuation allowance release of $32.2 million foreign tax credits.

(3)	Represents the net currency effects of translating valuation allowances at current rates of exchange.

(4)	Increase in valuation is primarily due to $11.9 million that was recorded on the foreign tax credit carryforward due to the disposal of the Company’s Grow Tech segment. The additional amount is due to net operating losses in foreign markets.

(5)	No decreases in 2021.

(6)	Increase in valuation is due primarily to net operating losses in foreign markets.

(7)	The decrease was due primarily to the utilization of foreign tax credits that had previously had a valuation allowance recorded against the asset.

The components of deferred taxes, net on a jurisdiction basis are as follows (U.S. dollars in thousands):

	Year Ended December 31,
	2022		2021
Net noncurrent deferred tax assets	$	89,770	$	26,483
Net noncurrent deferred tax liabilities		439		2,385
Deferred taxes, net	$	89,331	$	24,098

The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in proposed assessments that may result in additional tax liabilities.

The actual tax rate for the years ended December 31, 2022, 2021 and 2020 compared to the statutory U.S. Federal tax rate is as follows:

	Year Ended December 31,
	2022			2021			2020
Income taxes at statutory rate		21.00	%		21.00	%		21.00	%
Excess tax benefit from equity award		(0.12	)%		(0.19	)%		0.70	%
Deferred compensation		2.18	%		(0.46	)%		(0.30	)%
Executive salary limitation		2.06	%		0.47	%		0.04	%
Non-U.S. income taxed at different rates		4.78	%		6.06	%		3.37	%
Foreign withholding taxes		(0.73	)%		4.71	%		5.21	%
Change in reserve for uncertain tax positions		17.69	%		(0.06	)%		1.98	%
Valuation allowance recognized foreign tax credit & others		(56.17	)%		5.12	%		(4.59	)%
Foreign-Derived Intangible Income (FDII)		(8.14	)%		(0.87	)%		(2.78	)%
Other		(0.32	)%		0.87	%		0.69	%
		(17.77	)%		36.65	%		25.32	%

The decrease in effective tax rate for the 2022 was primarily due to the Company making an election to change its capitalization policy for tax purposes related to certain direct and indirect costs for inventory and self-constructed assets under Internal Revenue Code (“IRC”) Section 263A. This method change allows the Company to utilize a portion of its tax attributes related to foreign tax credits in the United States that were previously fully reserved. The increase in the effective tax rate for 2021 was primarily caused by the disposal of the Company’s Grow Tech segment which reduced the utilization of foreign tax credits and increased the Company’s valuation allowance.

The cumulative amount of undistributed earnings of the Company’s non-U.S. Subsidiaries held for indefinite reinvestment is approximately $60.0 million, at December 31, 2022. If this amount were repatriated to the United States, the amount of incremental taxes would be approximately $6.0 million.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Employee Benefit Plan

12 Months Ended

Dec. 31, 2022

Employee Benefit Plan [Abstract]

Employee Benefit Plan

12.	Employee Benefit Plan

The Company has a 401(k) defined-contribution plan which permits participating employees to defer up to a maximum of 100% of their compensation, subject to limitations established by the IRS. Employees age 18 and older are eligible to contribute to the plan starting the first day of employment. After completing at least one day of service, employees are eligible to receive matching contributions from the Company. In 2022, 2021, and 2020 the Company provided matching contributions of up to 4% of employees’ compensation each year. The Company’s matching contributions cliff vest after two years of service. The Company recorded compensation expense of $3.8 million, $4.8 million and $4.4 million for the years ended December 31, 2022, 2021 and 2020, respectively, related to its contributions to the plan. The Company may make additional discretionary contributions to the plan of up to 10% of employees’ base pay. The Company’s discretionary contributions vest 20% per year for an employee’s first five years of service. For the years ended December 31, 2022, 2021 and 2020, the Company did not make any additional discretionary contributions.

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI https://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

+ Details

Deferred Compensation Plan

12 Months Ended

Dec. 31, 2022

Deferred Compensation Plan [Abstract]

Deferred Compensation Plan

13.	Deferred Compensation Plan

The Company has a deferred compensation plan for select management personnel, highly compensated employees, and members of the Company’s board of directors. Under this plan, the Company may make discretionary contributions to participants’ deferred compensation accounts; prior to 2021, the Company historically contributed 10% of base salary for participants above a specified job level. In addition, each participant has the option to defer a portion of their compensation up to a maximum of 80% of their base salary and 100% of their bonuses or director fees. Participant contributions are immediately vested. Company contributions made on or prior to December 31, 2020 will vest 50% after ten years of service and 5% each year of service thereafter. In addition, any unvested company contributions will fully vest on the earlier of: (a) the participant attaining 60 years of age; and (b) death or disability.

Effective January 1, 2021, the Company amended its deferred compensation plan. Under the revision, the Company shall make matching contributions up to 5% of base salary for participants above a specified job level. The revision continues to authorize the Company to make discretionary contributions to participants’ deferred compensation accounts. In view of the opportunity to receive a 5% match, the Company reduced its discretionary contributions to 5% of base salary each year, though the Company is not obligated to make these contributions. Under the revision, the amounts contributed by the Company, adjusted for earnings and losses thereon, will vest 20% per year over five years, subject to acceleration upon the occurrence of certain events, including the completion of at least ten years of employment above a specified job level. All amounts a participant elects to defer, adjusted for earnings and losses thereon, are 100% vested at all times.

The Company recorded compensation expense of $2.3 million, $4.0 million and $2.3 million for the years ended December 31, 2022, 2021 and 2020, respectively, related to its contributions to the plan. The total long-term deferred compensation liability under the deferred compensation plan was $44.4 million and $54.2 million for the years ended December 31, 2022 and 2021, respectively, related to its contributions to the plan and is included in other long-term liabilities.

All benefits under the deferred compensation plan are unsecured obligations of the Company. The Company has contributed assets to a “rabbi trust” for the payment of benefits under the deferred compensation plan. As the assets of the trust are available to satisfy the claims of general creditors if the Company becomes insolvent, the amounts held in the trust are accounted for as an investment on the Company’s consolidated balance sheets of $40.1 million and $49.9 million for the years ended December 31, 2022 and 2021, respectively.

Derivative Financial Instruments

12 Months Ended

Dec. 31, 2022

Derivative Financial Instruments [Abstract]

Derivative Financial Instruments

14.	Derivative Financial Instruments

Risk Management Objective of Using Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During 2022, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.

For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income and subsequently reclassified into interest expense/income in the same period(s) during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense/income as interest payments are made/received on the Company’s variable-rate debt. During the next twelve months, the Company estimates that an additional $9.2 million will be reclassified as a reduction to interest expense.

As of December 31, 2022, the Company had four outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk with a total notional amount of $200 million.

Fair Values of Derivative Instruments on the Balance Sheet

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet:

		Fair Values of Derivative Instruments
		December 31,
Derivatives in Cash Flow Hedging Relationships:	Balance Sheet Location	2022		2021
Interest Rate Swap - Asset	Prepaid expenses and other	$	9,156	$	557
Interest Rate Swap - Asset	Other assets	$	10,582	$	6,033

Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income

The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income.

	Amount of Gain (Loss) Recognized in OCI on Derivatives
	Year Ended December 31,
Derivatives in Cash Flow Hedging Relationships:	2022		2021		2020
Interest Rate Swaps	$	16,267	$	5,391	$	1,017

		Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income
		Year Ended December 31,
Derivatives in Cash Flow Hedging Relationships:	Income Statement Location	2022		2021			2020
Interest Rate Swaps	Other income (expense), net	$	3,117	$	(157	)	$	(24	)

Segment Information

12 Months Ended

Dec. 31, 2022

Segment Information [Abstract]

Segment Information

15.	Segment Information

The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments—Americas, Mainland China, Southeast Asia/Pacific, South Korea, Japan, EMEA, and Hong Kong/Taiwan—and two Rhyz Investments segments—Manufacturing and Rhyz other. The Nu Skin other category includes miscellaneous corporate revenue and related adjustments. The Rhyz other segment includes other investments by our Rhyz strategic investment arm. These segments reflect the way the chief operating decision maker evaluates the Company’s business performance and allocates resources. Reported revenue includes only the revenue generated by sales to external customers.

Profitability by segment as determined under US GAAP is driven primarily by the Company’s transfer pricing policies. Segment contribution, which is the Company’s segment profitability metric presented in the table below, excludes certain intercompany charges, specifically royalties, license fees, transfer pricing, discrete charges and other miscellaneous items. These charges have been included in Corporate and other expenses. Corporate and other expenses also include costs related to the Company’s executive and administrative offices, information technology, research and development, and marketing and supply chain functions not recorded at the segment level.

Prior year segment information has been recast to reflect the fourth quarter of 2021 exit of the Grow Tech segment, which has been recast to Corporate and other expense. Prior year segment information has been recast to reflect the move of the Pacific components from the “America/Pacific” operating segments to the “Southeast Asia/Pacific” operating segment to comply with current segment presentation. Prior year segment information has been recast for a first quarter of 2021 change in the Company’s transfer pricing policies in the Americas segment, the 2020 Americas and Corporate and other segment contribution has been recast to conform with the new policy. Consolidated financial information is not affected.

The accounting policies of the segments are the same as those described in Note 2, “Summary of Significant Accounting Policies.” The Company evaluates the performance of its segments based on revenue and segment contribution. Each segment records direct expenses related to its employees and its operations.

Summarized financial information for the Company’s reportable segments is shown in the following tables. Asset information is not reviewed or included with the Company’s internal management reporting. Therefore, the Company has not disclosed asset information for each reportable segment.

Revenue by Segment

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
Nu Skin
Americas	$	508,537	$	547,755	$	453,022
Mainland China		360,389		568,774		625,538
Southeast Asia/Pacific		344,411		336,651		361,627
South Korea		268,707		354,252		326,478
Japan		224,896		266,216		273,681
EMEA		204,275		283,200		230,246
Hong Kong/Taiwan		157,197		162,611		161,117
Nu Skin Other		3,959		3,653		886
Total Nu Skin		2,072,371		2,523,112		2,432,595
Rhyz Investments
Manufacturing ⁽¹⁾		149,458		172,120		149,339
Rhyz Other		3,830		437		—
Total Rhyz Investments		153,288		172,557		149,339
Total	$	2,225,659	$	2,695,669	$	2,581,934

(1)	The Manufacturing segment had $69.2 million, $84.5 million and $39.4 million of intersegment revenue for the years ended December 31, 2022, 2021 and 2020, respectively. Intersegment revenue is eliminated in the consolidated financial statements and in the table above.

Segment Contribution

	Year Ended December 31,
(U.S. dollars in thousands)	2022			2021			2020
Nu Skin
Americas	$	110,522		$	116,265		$	86,386
Mainland China		72,362			151,645			181,024
Southeast Asia/Pacific		85,827			81,779			87,753
South Korea		81,804			114,034			100,933
Japan		54,976			67,511			68,027
EMEA		21,446			41,988			24,078
Hong Kong/Taiwan		35,253			37,330			33,466
Nu Skin contribution		462,190			610,552			581,667
Rhyz Investments
Manufacturing		3,570			18,346			21,168
Rhyz Other		(6,180	)		(1,813	)		—
Rhyz Investments contribution		(2,610	)		16,533			21,168
Total segment contribution		459,580			627,085			602,835
Corporate and other		(348,733	)		(393,093	)		(345,271	)
Operating income		110,847			233,992			257,564
Other income (expense)		(21,877	)		(1,533	)		(1,332	)
Income before provision for income taxes	$	88,970		$	232,459		$	256,232

Depreciation and Amortization

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
Nu Skin
Americas	$	591	$	871	$	984
Mainland China		12,177		13,345		11,056
Southeast Asia/Pacific		1,500		1,450		1,670
South Korea		1,616		3,279		3,620
Japan		1,011		906		1,876
EMEA		854		1,106		1,017
Hong Kong/Taiwan		3,743		3,637		2,912
Total Nu Skin		21,492		24,594		23,135
Rhyz Investments
Manufacturing		13,838		11,765		8,081
Rhyz Other		2,368		1,579		—
Total Rhyz Investments		16,206		13,344		8,081
Corporate and other		34,808		38,382		42,775
Total	$	72,506	$	76,320	$	73,991

Capital Expenditures

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
Nu Skin
Americas	$	204	$	714	$	1,061
Mainland China		10,692		24,382		19,363
Southeast Asia/Pacific		263		1,330		2,197
South Korea		727		854		1,420
Japan		225		194		3,128
EMEA		1,612		1,242		1,875
Hong Kong/Taiwan		3,338		736		708
Total Nu Skin		17,061		29,452		29,752
Rhyz Investments
Manufacturing		7,301		14,022		14,366
Rhyz Other		—		—		—
Total Rhyz Investments		7,301		14,022		14,366
Corporate and other		34,694		25,141		19,705
Total	$	59,056	$	68,615	$	63,823

Revenue by Major Market

A major market is defined as one with total revenue greater than 10% of consolidated total revenue. Based on this criteria, the Company has identified four major markets: Mainland China, South Korea, United States, and Japan. There are approximately 45 other markets, each of which individually is less than 10%. No single customer accounted for 10% or more of net sales for the periods presented. Sales are recorded in the jurisdiction in which the transactions occurred:

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
United States	$	537,081	$	540,253	$	425,155
Mainland China		360,389		568,774		625,538
South Korea		268,707		354,252		326,478
Japan		224,896		266,216		273,681
All others		834,586		966,174		931,082
Total	$	2,225,659	$	2,695,669	$	2,581,934

Revenue by Product Line

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
Beauty	$	1,069,714	$	1,442,659	$	1,491,803
Wellness		992,338		1,062,549		922,553
Other		163,607		190,461		167,578
Total	$	2,225,659	$	2,695,669	$	2,581,934

Long-Lived Assets by Major Market

A major market is defined as a market with long-lived assets greater than 10% of consolidated long-lived assets and also includes the Company’s country of domicile (the United States). Long-lived assets in Mainland China consist primarily of property, plant and equipment related to manufacturing, distribution facilities and the Mainland China headquarters. Long-lived assets in the United States consist primarily of property, plant and equipment, including the Company’s corporate offices and distribution facilities. Long-lived assets by major market are set forth below for the periods ended December 31, 2022, 2021 and 2020:

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
United States	$	343,482	$	335,020	$	348,028
Mainland China		132,148		149,124		152,312
South Korea		30,867		25,364		39,104
Japan		18,011		23,929		31,085
All others		33,291		47,687		62,141
Total	$	557,799	$	581,124	$	632,670

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

+ Details

Commitments and Contingencies

12 Months Ended

Dec. 31, 2022

Commitments and Contingencies [Abstract]

Commitments and Contingencies

16.	Commitments and Contingencies

The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company’s direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company’s sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company’s operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. No assurance can be given that the Company’s compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company’s financial position, results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation, investigations and other proceedings involving various matters. The Company is subject to loss contingencies, including various legal and regulatory proceedings, asserted and potential claims that arise in the ordinary course of business. An estimated loss from such contingencies is recognized as a charge to income if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated.

The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company’s reserves, which would impact its reported financial results.

Other Income (Expense), Net

12 Months Ended

Dec. 31, 2022

Other Income (Expense), Net [Abstract]

Other Income (Expense), Net

17.	Other Income (Expense), Net

Other income (expense), net was $21.9 million, $1.5 million and $1.3 million of expense in 2022, 2021 and 2020, respectively. Other income (expense), net includes $13.5 million, $11.0 million and $13.1 million in interest expense during 2022, 2021 and 2020, respectively.

Supplemental Cash Flow Information

12 Months Ended

Dec. 31, 2022

Supplemental Cash Flow Information [Abstract]

Supplemental Cash Flow Information

18.	Supplemental Cash Flow Information

Cash paid for interest totaled $14.5 million, $8.6 million and $11.2 million for the years ended December 31, 2022, 2021 and 2020, respectively. Cash paid for income taxes totaled $42.1 million, $96.0 million and $56.2 million for the years ended December 31, 2022, 2021 and 2020, respectively.

Acquisitions

12 Months Ended

Dec. 31, 2022

Acquisitions [Abstract]

Acquisitions

19.	Acquisitions

In April 2021, the Company acquired 100% ownership in MyFavoriteThings, Inc. (“Mavely”) making Mavely a wholly owned subsidiary of the Company. The acquisition enables the Company to continue to expand its digital tools. The purchase price for Mavely was $16.8 million, net of cash acquired of $0.4 million and $0.9 million to be paid within six months, all payable in cash. In addition, there is potential for an incremental $24.0 million in contingent consideration, which becomes payable if certain revenue and profitability targets are reached in 2021, 2022 and 2023. The fair value of the contingent consideration recorded on the acquisition date was $8.7 million. The Company allocated the gross purchase price of $29.4 million to the assets acquired and liabilities assumed at estimated fair values. The estimated fair value of assets acquired included $16.4 million of intangible assets, $0.4 million of cash, $0.1 million of accounts receivable, and also resulted in a deferred tax liability of $3.5 million. The excess purchase price over the aggregate fair value of assets acquired less liabilities assumed of $12.6 million was recorded as goodwill. The goodwill recognized is attributable primarily to expected synergies. None of the goodwill is expected to be deductible for income tax purposes. The intangible assets acquired were comprised of $2.0 million for customer relationships, $11.3 million for technology, $2.8 million for trademarks and $0.3 million for other intangibles. The intangibles were assigned useful lives of 8 years for the technology and trademarks, approximately 4 years for the customer relationships and 3 years for the other intangibles. All the goodwill was assigned to our Rhyz other segment. The allocation of the fair value of assets acquired and liabilities assumed for the acquisition was finalized during the three months ended September 30, 2021.

Restructuring and Severance Charges

12 Months Ended

Dec. 31, 2022

Restructuring and Severance Charges [Abstract]

Restructuring and Severance Charges

20.	Restructuring and Severance Charges

In 2021, the Company determined to exit the Grow Tech segment, to better align its resources on key strategic initiatives to achieve the future growth objectives and priorities of the core Nu Skin business. The Grow Tech segment was pursuing the commercialization of controlled-environment agriculture for use in the agriculture feed industry. This segment has been operating as part of the Company’s Rhyz strategic investment arm. As a result of the restructuring program, the Company recorded a non-cash charge of $38.5 million in 2021, including $9.2 million for impairment of goodwill, $9.0 million for impairment of intangibles, $13.7 million of fixed asset impairments and $6.6 million for inventory write-off, and $20.0 million of cash charges, including $6.5 million for employee severance and $13.5 million for other related cash charges with our restructuring. The restructuring charges were recorded in the Grow Tech segment. As of December 31, 2021, the $20.0 million liability related to cash charges was recorded within Accrued expenses. During 2022, the Company incurred $5.0 million in incremental cash charges associated with the exit activities and legal settlements. During 2022, the Company made cash payments of $20.0 million, leaving a restructuring accrual of $5.0 million as of December 31, 2022.

In the third quarter of 2022, the Company adopted a strategic plan to focus resources on the Company’s strategic priorities and optimize future growth and profitability. The global program includes workforce reductions and footprint optimization. The Company estimates total charges under the program will approximate $50–$55 million, with $40–$45 million in cash charges of severance and lease termination cost and approximately $10 million of non-cash charges of impairment of fixed assets, acceleration of depreciation and impairment of other intangibles related to the footprint optimization. The Company expects to substantially complete the program during the first half of 2023. During 2022, the Company incurred charges to be settled in cash of $20.1 million in severance charges, $7.4 million in lease termination cost, and $5.2 million in other associated cost, and non-cash charges of $8.2 million in fixed asset impairments, $0.9 million in accelerated depreciation and $1.7 million in impairment of other intangibles. During 2022, the Company made cash payments of $21.0 million related to this global program, leaving an ending restructuring accrual of $11.7 million.

Restructuring expense by segment

(U.S. dollars in thousands)	Year Ended December 31, 2022

Nu Skin
Americas	$	1,687
Mainland China		13,181
Southeast Asia/Pacific		1,809
South Korea		1,533
Japan		699
EMEA		2,143
Hong Kong/Taiwan		2,464
Total Nu Skin		23,516
Rhyz Investments
Manufacturing		401
Rhyz other		—
Total Rhyz Investments		401
Corporate and other		19,577
Total	$	43,494

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2022

Summary of Significant Accounting Policies [Abstract]

Consolidation

The consolidated financial statements include the accounts of the Company and the Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Use of Estimates

Use of estimates

Reclassifications

Cash and Cash Equivalents

Cash and cash equivalents

Cash equivalents are short-term, highly liquid instruments with original maturities of 90 days or less.

Accounts Receivable

Accounts receivable

Inventories

Inventories consist of the following (U.S. dollars in thousands):

	December 31,
	2022		2021
Raw materials	$	163,797	$	179,891
Finished goods		182,386		220,040
Total inventory, net	$	346,183	$	399,931

Reserves of inventories consist of the following (U.S. dollars in thousands):

	2022			2021			2020
Beginning balance	$	18,643		$	14,249		$	12,295
Additions		43,286			31,300			15,952
Write-offs		(24,662	)		(26,906	)		(13,998	)
Ending balance	$	37,267		$	18,643		$	14,249

Property and Equipment

Property and equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation is recorded using the straight-line method over the following estimated useful lives:

Buildings	39 years
Furniture and fixtures	5 - 7 years
Computers and equipment	3 - 5 years
Leasehold improvements	Shorter of estimated useful life or lease term
Scanners	3 years
Vehicles	3 - 5 years

Leases

The Company has lease agreements with lease and non-lease components. The Company accounts for the lease and non-lease components as a single lease component.

Goodwill and Other Intangible Assets

Goodwill and other intangible assets

Equity Investments

Equity investments

Revenue Recognition

Revenue recognition

Contract Liabilities – Customer Loyalty Programs

Disaggregation of Revenue

Please refer to Note 15 - Segment Information for revenue by segment and product line.

Arrangements with Multiple Performance Obligations

Shipping and Handling Costs

Shipping and handling costs

Shipping and handling costs are recorded as cost of sales and are expensed as incurred.

Advertising Expenses

Advertising expenses

Selling Expenses

Selling expenses

Research and Development

Research and development

Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities

Uncertain Tax Positions

Uncertain tax positions

A reconciliation of the beginning and ending amount of unrecognized tax benefits included in other liabilities is as follows (U.S. dollars in thousands):

	2022			2021			2020
Gross balance at January 1	$	15,090		$	17,620		$	13,507
Increases related to prior year tax positions		6,768			4,146			2,958
Increases related to current year tax positions		5,485			1,794			3,302
Settlements		(2,590	)		(5,494	)		(1,091	)
Decreases due to lapse of statutes of limitations		(95	)		(2,409	)		(1,377	)
Currency adjustments		(1,559	)		(567	)		321
Gross balance at December 31	$	23,099		$	15,090		$	17,620

Net Income per Share

Net income per share

Foreign Currency Translation and Classification of a Highly Inflationary Economy

Foreign currency translation

Classification of a highly inflationary economy

Fair Value of Financial Instruments

Fair value of financial instruments

●

Level 1 – quoted prices in active markets for identical assets or liabilities;

●

Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;

●

Level 3 – unobservable inputs based on the Company’s own assumptions.

Stock-based Compensation

Stock-based compensation

Reporting Comprehensive Income

Reporting comprehensive income

Derivative Instruments and Hedging Activities

Derivative instruments and hedging activities

Recent Accounting Pronouncements

Recent accounting pronouncements

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2022

Summary of Significant Accounting Policies [Abstract]

Inventories

Inventories consist of the following (U.S. dollars in thousands):

	December 31,
	2022		2021
Raw materials	$	163,797	$	179,891
Finished goods		182,386		220,040
Total inventory, net	$	346,183	$	399,931

Inventory Reserves

Reserves of inventories consist of the following (U.S. dollars in thousands):

	2022			2021			2020
Beginning balance	$	18,643		$	14,249		$	12,295
Additions		43,286			31,300			15,952
Write-offs		(24,662	)		(26,906	)		(13,998	)
Ending balance	$	37,267		$	18,643		$	14,249

Prepaid Expenses and Other

Prepaid expenses and other consist of the following (U.S. dollars in thousands):

	December 31,
	2022		2021
Deferred charges	$	11,748	$	14,266
Prepaid income tax		9,333		2,784
Prepaid inventory and import costs		3,540		6,087
Prepaid rent, insurance and other occupancy costs		5,830		3,690
Prepaid promotion and event cost		2,395		4,382
Prepaid other taxes		8,768		9,333
Derivative financial instruments		9,156		557
Prepaid software license		17,463		17,041
Deposits		1,153		1,158
Other		18,430		17,608
Total prepaid expense and other	$	87,816	$	76,906

Estimated Useful Lives

Property and equipment are stated at cost less accumulated depreciation. Depreciation is recorded using the straight-line method over the following estimated useful lives:

Buildings	39 years
Furniture and fixtures	5 - 7 years
Computers and equipment	3 - 5 years
Leasehold improvements	Shorter of estimated useful life or lease term
Scanners	3 years
Vehicles	3 - 5 years

Other Assets

Other assets consist of the following (U.S. dollars in thousands):

	December 31,
	2022		2021
Deferred taxes	$	89,770	$	26,483
Deposits for noncancelable operating leases		13,872		17,121
Cash surrender value for life insurance policies		40,055		49,851
Right-of-use assets, Financing, net		14,259		6,477
Derivative financial instruments		10,582		6,033
Long-term investments		39,493		35,868
Other		36,398		33,627
Total other assets	$	244,429	$	175,460

Accrued Expenses

Accrued expenses consist of the following (U.S. dollars in thousands):

	December 31,
	2022		2021
Accrued sales force commissions and other payments	$	95,686	$	139,793
Accrued other taxes		21,822		31,135
Accrued payroll and other employee expenses		37,650		53,641
Accrued payable to vendors		29,569		45,347
Short-term operating lease liability		29,376		33,427
Accrued royalties		845		1,095
Sales return reserve		3,359		3,513
Deferred revenue		27,053		33,139
Other		34,920		31,111
Total accrued expenses	$	280,280	$	372,201

Other Liabilities

Other liabilities consist of the following (U.S. dollars in thousands):

	December 31,
	2022		2021
Deferred tax liabilities	$	439	$	2,385
Reserve for other tax liabilities		35,532		21,774
Liability for deferred compensation plan		44,427		54,213
Contingent consideration		6,364		10,341
Finance lease liabilities		12,140		5,318
Asset retirement obligation		5,978		5,408
Other		5,545		7,035
Total other liabilities	$	110,425	$	106,474

Unrecognized Tax Benefits

A reconciliation of the beginning and ending amount of unrecognized tax benefits included in other liabilities is as follows (U.S. dollars in thousands):

	2022			2021			2020
Gross balance at January 1	$	15,090		$	17,620		$	13,507
Increases related to prior year tax positions		6,768			4,146			2,958
Increases related to current year tax positions		5,485			1,794			3,302
Settlements		(2,590	)		(5,494	)		(1,091	)
Decreases due to lapse of statutes of limitations		(95	)		(2,409	)		(1,377	)
Currency adjustments		(1,559	)		(567	)		321
Gross balance at December 31	$	23,099		$	15,090		$	17,620

Property and Equipment (Tables)

12 Months Ended

Dec. 31, 2022

Property and Equipment [Abstract]

Property and Equipment

Property and equipment are comprised of the following (U.S. dollars in thousands):

	December 31,
	2022			2021
Land	$	42,931		$	45,027
Buildings		274,049			281,192
Construction in progress⁽¹⁾		64,566			44,021
Furniture and fixtures		136,835			147,786
Computers and equipment		145,934			162,746
Leasehold improvements		114,633			129,675
Scanners		6,438			6,746
Vehicles		1,606			2,021
		786,992			819,214
Less: accumulated depreciation		(342,186	)		(365,540	)
	$	444,806		$	453,674

(1)	Construction in progress includes $20.5 million and $11.0 million as of December 31, 2022 and 2021, respectively, of eligible capitalized internal-use software development costs which will be reclassified to computers and equipment when placed into service.

Goodwill (Tables)

12 Months Ended

Dec. 31, 2022

Goodwill [Abstract]

Goodwill

The following table presents goodwill allocated to the Company’s reportable segments for the periods ended December 31, 2022 and 2021 (U.S. dollars in thousands):

	December 31,
	2022		2021
Nu Skin
Americas	$	9,449	$	9,449
Mainland China		32,179		32,179
Southeast Asia/Pacific		18,537		18,537
South Korea		29,261		29,261
Japan		16,019		16,019
EMEA		2,875		2,875
Hong Kong/Taiwan		6,634		6,634
Rhyz Investments
Manufacturing		78,875		78,875
Rhyz Other		12,603		12,603
Total	$	206,432	$	206,432

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 55
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

+ Details

Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2022

Other Intangible Assets [Abstract]

Indefinite Life Intangible Assets

Other intangible assets consist of the following (U.S. dollars in thousands):

	Carrying Amount at December 31,
	2022		2021
Indefinite life intangible assets:
Trademarks and trade names	$	24,599	$	24,599

Finite Life Intangible Assets

	December 31, 2022				December 31, 2021
Finite life intangible assets:	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization		Weighted- average Amortization Period
Scanner technology	$	40,716	$	40,716	$	40,716	$	40,716	18 years
Developed technology		43,841		27,365		43,841		24,697	14 years
Sales force network		11,598		11,598		11,598		11,598	15 years
Trademarks		7,860		4,200		8,989		3,827	9 years
Other		48,285		26,319		51,176		23,090	8 years
	$	152,300	$	110,198	$	156,320	$	103,928	13 years

Future Amortization Expense

The estimated annual amortization expense for each of the five succeeding fiscal years are as follows (U.S. dollars in thousands):

Year Ending December 31,
2023	$	9,595
2024		9,108
2025		7,826
2026		6,222
2027		4,373

Long-Term Debt (Tables)

12 Months Ended

Dec. 31, 2022

Long-Term Debt [Abstract]

Debt Facilities

The following table summarizes the Company’s debt facilities as of December 31, 2022 and 2021:

Facility or Arrangement	Original Principal Amount	Balance as of December 31, 2022 ⁽¹⁾⁽²⁾	Balance as of December 31, 2021 ⁽¹⁾⁽²⁾	Interest Rate	Repayment Terms
2018 Credit Agreement term loan facility	$400.0 million	—	$307.5 million		Principal amount was paid in full during June 2022.

2018 Credit Agreement revolving credit facility		—	$70.0 million		Principal amount was paid in full during June 2022 and credit line was closed.

Credit Agreement term loan facility	$400.0 million	$395.0 million	—	Variable 30 day: 6.17%	21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term.

Credit Agreement revolving credit facility		$10.0 million	—	Variable 30 day: 6.17%	Revolving line of credit expires June 14, 2027.

(1)	As of December 31, 2022 and 2021, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $15.0 million and $37.5 million, respectively, of the balance of its term loan under the Credit Agreement and 2018 Credit Agreement.

(2)	The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.5 million and $1.2 million as of December 31, 2022 and 2021, respectively, related to the Credit Agreement and 2018 Credit Agreement, which are not reflected in this table.

Maturities of Long-Term Debt

Maturities of all long-term debt at December 31, 2022, are as follows (U.S. dollars in thousands):

Year Ending December 31,
2023	$	15,000
2024		20,000
2025		20,000
2026		20,000
2027		320,000
Thereafter		—
Total ⁽¹⁾	$	395,000

(1)	The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $2.5 million, which is not reflected in this table.

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69B
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69E
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Leases (Tables)

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Components of Lease Expense

The components of lease expense were as follows (U.S. dollars in thousands):

	Year Ended December 31,
	2022		2021			2020
Operating lease expense
Operating lease cost	$	39,682	$	48,447		$	51,828
Variable lease cost		6,061		5,734			4,366
Short-term lease cost		210		592			1,056
Sublease income		—		(5,663	)		(5,052	)
Finance lease expense
Amortization of right-of-use assets		2,371		2,398			1,023
Interest on lease liabilities		268		319			154
Total lease expense	$	48,592	$	51,827		$	53,375

Supplemental Cash Flow Information Related to Leases

Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands):

	Year Ended December 31,
	2022		2021		2020
Operating cash outflow from operating leases	$	37,174	$	51,570	$	56,395
Operating cash outflow from finance leases	$	243	$	322	$	138
Financing cash outflow from finance leases	$	1,919	$	1,871	$	709
Right-of-use assets obtained in exchange for operating lease obligations	$	34,026	$	25,427	$	82,662
Right-of-use assets obtained in exchange for finance lease obligations	$	9,797	$	74	$	9,206

Maturities of Lease Liabilities

Maturities of lease liabilities were as follows (U.S. dollars in thousands):

Year Ending December 31,	Operating Leases		Finance Leases
2023	$	26,086	$	3,836
2024		18,808		3,428
2025		13,338		3,371
2026		8,692		3,277
2027		7,690		2,933
Thereafter		42,385		—
Total		116,999		16,845
Less: Finance charges		15,542		1,362
Total principal liability	$	101,457	$	15,483

Capital Stock (Tables)

12 Months Ended

Dec. 31, 2022

Capital Stock [Abstract]

Weighted-Average Common Shares Outstanding

The following is a reconciliation of the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands):

	Year Ended December 31,
	2022		2021		2020
Basic weighted-average common shares outstanding		50,002		50,193		52,296
Effect of dilutive securities:
Stock awards and options		523		1,234		469
Diluted weighted-average common shares outstanding		50,525		51,427		52,765

Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Stock-Based Compensation [Abstract]

Stock Option Valuation Assumptions

The fair value of stock option awards was estimated using the Black-Scholes option-pricing model with the following assumptions and weighted-average fair values as follows:

	December 31,
Stock Options:	2021			2020
Weighted-average grant date fair value of grants	$	16.10		$	8.59
Risk-free interest rate⁽¹⁾		0.5	%		1.4	%
Dividend yield⁽²⁾		2.9	%		2.9	%
Expected volatility⁽³⁾		49.5	%		40.7	%
Expected life in months⁽⁴⁾	56 months			59 months

(1)	The risk-free interest rate is based upon the rate on a zero-coupon U.S. Treasury bill, for periods within the contractual life of the option, in effect at the time of the grant.

(2)	The dividend yield is based on the average of historical stock prices and actual dividends paid.

(3)	Expected volatility is based on the historical volatility of the Company’s stock price, over a period similar to the expected life of the option.

(4)	The expected term of the option is based on the historical employee exercise behavior, the vesting terms of the respective option, and a contractual life of either seven or ten years.

Stock Options

Options under the plans as of December 31, 2022 and changes during the year ended December 31, 2022 were as follows:

	Shares (in thousands)			Weighted- average Exercise Price		Weighted- average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Options activity – service based
Outstanding at December 31, 2021		538.2		$	35.89
Granted		—			—
Exercised		(340.0	)		33.15
Forfeited/cancelled/expired		(34.3	)		54.45
Outstanding at December 31, 2022		163.9			37.69		0.35	$	834
Exercisable at December 31, 2022		163.9			37.69		0.35		834

Options activity – performance based
Outstanding at December 31, 2021		2,220.1		$	40.87
Granted		—			—
Exercised		(340.5	)		31.14
Forfeited/cancelled/expired		(418.0	)		50.66
Outstanding at December 31, 2022		1,461.6			40.30		3.89	$	9,515
Exercisable at December 31, 2022		958.6			39.46		3.41		7,193

Options activity – all options
Outstanding at December 31, 2021		2,758.3		$	39.90
Granted		—			—
Exercised		(680.5	)		31.65
Forfeited/cancelled/expired		(452.3	)		50.95
Outstanding at December 31, 2022		1,625.5			40.04		3.53	$	10,349
Exercisable at December 31, 2022		1,122.5			39.20		2.96		8,027

Stock Options Exercised

Cash proceeds, tax benefits and intrinsic value related to total stock options exercised during 2022, 2021 and 2020, were as follows (U.S. dollars in thousands):

	December 31,
	2022		2021		2020
Cash proceeds from stock options exercised	$	31,600	$	14,435	$	7,419
Tax benefit / (expense) realized for stock options exercised		229		807		(459	)
Intrinsic value of stock options exercised		15,505		8,402		5,232

Nonvested Restricted Stock Awards

Nonvested restricted stock awards as of December 31, 2022 and changes during the year ended December 31, 2022 were as follows:

	Number of Shares (in thousands)			Weighted- average Grant Date Fair Value
Nonvested at December 31, 2021		884.9		$	44.11

Granted		587.1			46.04
Vested		(326.6	)		47.03
Forfeited		(192.4	)		44.01

Nonvested at December 31, 2022		953.0		$	44.28

Nonvested Performance Share Units

Nonvested performance share units as of December 31, 2022 and changes during the year ended December 31, 2022 were as follows:

	Number of Shares (in thousands)			Weighted- average Grant Date Fair Value
Nonvested at December 31, 2021		—		$	—

Granted		192.7			44.39
Vested		—			—
Forfeited		(12.5	)		44.39

Nonvested at December 31, 2022		180.2		$	44.39

Fair Value and Equity Investments (Tables)

12 Months Ended

Dec. 31, 2022

Fair Value and Equity Investments [Abstract]

Assets (Liabilities) Measured at Fair Value on a Recurring Basis

The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands):

	Fair Value at December 31, 2022
	Level 1		Level 2		Level 3			Total
Financial assets (liabilities):
Cash equivalents and current investments	$	55,356	$	—	$	—		$	55,356
Derivative financial instruments asset		—		19,738		—			19,738
Life insurance contracts		—		—		40,055			40,055
Contingent consideration		—		—		(6,364	)		(6,364	)
Total	$	55,356	$	19,738		33,691		$	108,785

	Fair Value at December 31, 2021
	Level 1		Level 2		Level 3			Total
Financial assets (liabilities):
Cash equivalents and current investments	$	66,477	$	—	$	—		$	66,477
Derivative financial instruments asset		—		6,590		—			6,590
Life insurance contracts		—		—		49,851			49,851
Contingent consideration		—		—		(10,341	)		(10,341	)
Total	$	66,477	$	6,590	$	39,510		$	112,577

Changes in Fair Value of Level 3 Life Insurance Contracts

The following table provides a summary of changes in fair value of the Company’s Level 3 life insurance contracts (U.S. dollars in thousands):

	2022			2021
Beginning balance at January 1	$	49,851		$	45,453
Actual return on plan assets		(9,180	)		5,153
Purchases and issuances		—			6,261
Sales and settlements		(616	)		(7,016	)
Ending balance at December 31	$	40,055		$	49,851

Changes in Fair Value of Level 3 Contingent Consideration

The following table provides a summary of changes in fair value of the Company’s Level 3 contingent consideration (U.S. dollars in thousands):

	2022			2021
Beginning balance at January 1	$	(10,341	)	$	(3,125	)
Additions from acquisitions		—			(8,702	)
Changes in fair value of contingent consideration		3,977			1,486
Ending balance at December 31	$	(6,364	)	$	(10,341	)

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2022

Income Taxes [Abstract]

Consolidated Income Before Provision for Income Taxes

Consolidated income before provision for income taxes consists of the following for the years ended December 31, 2022, 2021 and 2020 (U.S. dollars in thousands):

	2022		2021		2020
U.S.	$	24,411	$	45,371	$	71,138
Foreign		64,559		187,088		185,094
Total	$	88,970	$	232,459	$	256,232

Current and Deferred Taxes

The provision for current and deferred taxes for the years ended December 31, 2022, 2021 and 2020 consists of the following (U.S. dollars in thousands):

	2022			2021			2020
Current
Federal	$	—		$	—		$	—
State		1,515			1,458			1,629
Foreign		34,117			77,393			77,079
		35,632			78,851			78,708
Deferred
Federal		(65,733	)		3,705			(14,430	)
State		(1,239	)		(38	)		(563	)
Foreign		15,532			2,675			1,162
		(51,440	)		6,342			(13,831	)
Provision for income taxes	$	(15,808	)	$	85,193		$	64,877

Deferred Tax Assets and Liabilities

The principal components of deferred taxes are as follows (U.S. dollars in thousands):

	Year Ended December 31,
	2022			2021
Deferred tax assets:
Inventory differences	$	41,127		$	5,859
Foreign tax credit and other foreign benefits		51,273			69,401
Stock-based compensation		5,981			9,392
Accrued expenses not deductible until paid		37,181			36,401
Foreign currency exchange		—			605
Net operating losses		12,773			9,479
Capitalized research and development		26,406			22,962
R&D credit carryforward		1,795			1,451
Other		242			34
Gross deferred tax assets		176,778			155,584
Deferred tax liabilities:
Foreign currency exchange		3,225			—
Foreign withholding taxes		15,375			15,412
Intangibles step-up		4,446			4,446
Overhead allocation to inventory		3,504			3,373
Amortization of intangibles		21,211			21,936
Other		6,129			6,133
Gross deferred tax liabilities		53,890			51,300
Valuation allowance		(33,557	)		(80,186	)
Deferred taxes, net	$	89,331		$	24,098

Deferred Tax Asset Valuation Adjustments

The deferred tax asset valuation adjustments for the years ended December 31, 2022, 2021 and 2020 are as follows (U.S. dollars in thousands):

	Year Ended December 31,
	2022			2021			2020
Balance at the beginning of period	$	80,186		$	67,340		$	77,042
Additions charged to cost and expenses		3,231	⁽¹⁾		12,674	⁽⁴⁾		2,154	⁽⁶⁾
Decreases		(50,315	)⁽²⁾		—	⁽⁵⁾		(12,100	)⁽⁷⁾
Adjustments		455	⁽³⁾		172	⁽³⁾		244	⁽³⁾
Balance at the end of the period	$	33,557		$	80,186		$	67,340

(1)	Increase in valuation is due primarily to net operating losses in foreign markets.

(2)	The decrease was due to utilization of $18.1 million of foreign tax credits and the valuation allowance release of $32.2 million foreign tax credits.

(3)	Represents the net currency effects of translating valuation allowances at current rates of exchange.

(4)	Increase in valuation is primarily due to $11.9 million that was recorded on the foreign tax credit carryforward due to the disposal of the Company’s Grow Tech segment. The additional amount is due to net operating losses in foreign markets.

(5)	No decreases in 2021.

(6)	Increase in valuation is due primarily to net operating losses in foreign markets.

(7)	The decrease was due primarily to the utilization of foreign tax credits that had previously had a valuation allowance recorded against the asset.

Deferred Taxes, Net on a Jurisdiction Basis

The components of deferred taxes, net on a jurisdiction basis are as follows (U.S. dollars in thousands):

	Year Ended December 31,
	2022		2021
Net noncurrent deferred tax assets	$	89,770	$	26,483
Net noncurrent deferred tax liabilities		439		2,385
Deferred taxes, net	$	89,331	$	24,098

Reconciliation of Statutory to Effective Tax Rate

The actual tax rate for the years ended December 31, 2022, 2021 and 2020 compared to the statutory U.S. Federal tax rate is as follows:

	Year Ended December 31,
	2022			2021			2020
Income taxes at statutory rate		21.00	%		21.00	%		21.00	%
Excess tax benefit from equity award		(0.12	)%		(0.19	)%		0.70	%
Deferred compensation		2.18	%		(0.46	)%		(0.30	)%
Executive salary limitation		2.06	%		0.47	%		0.04	%
Non-U.S. income taxed at different rates		4.78	%		6.06	%		3.37	%
Foreign withholding taxes		(0.73	)%		4.71	%		5.21	%
Change in reserve for uncertain tax positions		17.69	%		(0.06	)%		1.98	%
Valuation allowance recognized foreign tax credit & others		(56.17	)%		5.12	%		(4.59	)%
Foreign-Derived Intangible Income (FDII)		(8.14	)%		(0.87	)%		(2.78	)%
Other		(0.32	)%		0.87	%		0.69	%
		(17.77	)%		36.65	%		25.32	%

Derivative Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2022

Derivative Financial Instruments [Abstract]

Fair Value of Derivative Instruments on the Balance Sheet

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet:

		Fair Values of Derivative Instruments
		December 31,
Derivatives in Cash Flow Hedging Relationships:	Balance Sheet Location	2022		2021
Interest Rate Swap - Asset	Prepaid expenses and other	$	9,156	$	557
Interest Rate Swap - Asset	Other assets	$	10,582	$	6,033

Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income

The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income.

	Amount of Gain (Loss) Recognized in OCI on Derivatives
	Year Ended December 31,
Derivatives in Cash Flow Hedging Relationships:	2022		2021		2020
Interest Rate Swaps	$	16,267	$	5,391	$	1,017

		Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income
		Year Ended December 31,
Derivatives in Cash Flow Hedging Relationships:	Income Statement Location	2022		2021			2020
Interest Rate Swaps	Other income (expense), net	$	3,117	$	(157	)	$	(24	)

Segment Information (Tables)

12 Months Ended

Dec. 31, 2022

Segment Information [Abstract]

Revenue by Segment

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
Nu Skin
Americas	$	508,537	$	547,755	$	453,022
Mainland China		360,389		568,774		625,538
Southeast Asia/Pacific		344,411		336,651		361,627
South Korea		268,707		354,252		326,478
Japan		224,896		266,216		273,681
EMEA		204,275		283,200		230,246
Hong Kong/Taiwan		157,197		162,611		161,117
Nu Skin Other		3,959		3,653		886
Total Nu Skin		2,072,371		2,523,112		2,432,595
Rhyz Investments
Manufacturing ⁽¹⁾		149,458		172,120		149,339
Rhyz Other		3,830		437		—
Total Rhyz Investments		153,288		172,557		149,339
Total	$	2,225,659	$	2,695,669	$	2,581,934

(1)	The Manufacturing segment had $69.2 million, $84.5 million and $39.4 million of intersegment revenue for the years ended December 31, 2022, 2021 and 2020, respectively. Intersegment revenue is eliminated in the consolidated financial statements and in the table above.

Segment Contribution

	Year Ended December 31,
(U.S. dollars in thousands)	2022			2021			2020
Nu Skin
Americas	$	110,522		$	116,265		$	86,386
Mainland China		72,362			151,645			181,024
Southeast Asia/Pacific		85,827			81,779			87,753
South Korea		81,804			114,034			100,933
Japan		54,976			67,511			68,027
EMEA		21,446			41,988			24,078
Hong Kong/Taiwan		35,253			37,330			33,466
Nu Skin contribution		462,190			610,552			581,667
Rhyz Investments
Manufacturing		3,570			18,346			21,168
Rhyz Other		(6,180	)		(1,813	)		—
Rhyz Investments contribution		(2,610	)		16,533			21,168
Total segment contribution		459,580			627,085			602,835
Corporate and other		(348,733	)		(393,093	)		(345,271	)
Operating income		110,847			233,992			257,564
Other income (expense)		(21,877	)		(1,533	)		(1,332	)
Income before provision for income taxes	$	88,970		$	232,459		$	256,232

Depreciation and Amortization and Capital Expenditures

Depreciation and Amortization

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
Nu Skin
Americas	$	591	$	871	$	984
Mainland China		12,177		13,345		11,056
Southeast Asia/Pacific		1,500		1,450		1,670
South Korea		1,616		3,279		3,620
Japan		1,011		906		1,876
EMEA		854		1,106		1,017
Hong Kong/Taiwan		3,743		3,637		2,912
Total Nu Skin		21,492		24,594		23,135
Rhyz Investments
Manufacturing		13,838		11,765		8,081
Rhyz Other		2,368		1,579		—
Total Rhyz Investments		16,206		13,344		8,081
Corporate and other		34,808		38,382		42,775
Total	$	72,506	$	76,320	$	73,991

Capital Expenditures

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
Nu Skin
Americas	$	204	$	714	$	1,061
Mainland China		10,692		24,382		19,363
Southeast Asia/Pacific		263		1,330		2,197
South Korea		727		854		1,420
Japan		225		194		3,128
EMEA		1,612		1,242		1,875
Hong Kong/Taiwan		3,338		736		708
Total Nu Skin		17,061		29,452		29,752
Rhyz Investments
Manufacturing		7,301		14,022		14,366
Rhyz Other		—		—		—
Total Rhyz Investments		7,301		14,022		14,366
Corporate and other		34,694		25,141		19,705
Total	$	59,056	$	68,615	$	63,823

Revenue by Major Market

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
United States	$	537,081	$	540,253	$	425,155
Mainland China		360,389		568,774		625,538
South Korea		268,707		354,252		326,478
Japan		224,896		266,216		273,681
All others		834,586		966,174		931,082
Total	$	2,225,659	$	2,695,669	$	2,581,934

Revenue by Product Line

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
Beauty	$	1,069,714	$	1,442,659	$	1,491,803
Wellness		992,338		1,062,549		922,553
Other		163,607		190,461		167,578
Total	$	2,225,659	$	2,695,669	$	2,581,934

Long-Lived Assets by Major Market

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2021		2020
United States	$	343,482	$	335,020	$	348,028
Mainland China		132,148		149,124		152,312
South Korea		30,867		25,364		39,104
Japan		18,011		23,929		31,085
All others		33,291		47,687		62,141
Total	$	557,799	$	581,124	$	632,670

Restructuring and Severance Charges (Tables)

12 Months Ended

Dec. 31, 2022

Restructuring and Severance Charges [Abstract]

Restructuring Expense by Segment

Restructuring expense by segment

(U.S. dollars in thousands)	Year Ended December 31, 2022

Nu Skin
Americas	$	1,687
Mainland China		13,181
Southeast Asia/Pacific		1,809
South Korea		1,533
Japan		699
EMEA		2,143
Hong Kong/Taiwan		2,464
Total Nu Skin		23,516
Rhyz Investments
Manufacturing		401
Rhyz other		—
Total Rhyz Investments		401
Corporate and other		19,577
Total	$	43,494

The Company (Details)	12 Months Ended
The Company (Details)	Dec. 31, 2022 Segment
The Company [Abstract]
Number of reportable segments	9
Number of geographic segments	7
Number of Rhyz Investments segments	2

Summary of Significant Accounting Policies, Reclassifications (Details) - Reclassification Adjustment [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
General and Administrative Expenses [Member]
Reclassifications [Abstract]
Events and other miscellaneous selling costs	$ (12.0)	$ (10.4)
Selling Expenses [Member]
Reclassifications [Abstract]
Events and other miscellaneous selling costs	$ 12.0	$ 10.4

Summary of Significant Accounting Policies, Inventories (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Inventories [Abstract]
Raw materials	$ 163,797	$ 179,891
Finished goods	182,386	220,040
Total Inventory, net	346,183	399,931
Inventory Valuation Reserve [Member]
Valuation Allowance [Roll Forward]
Beginning balance	18,643	14,249	$ 12,295
Additions	43,286	31,300	15,952
Write-offs	(24,662)	(26,906)	(13,998)
Ending balance	$ 37,267	$ 18,643	$ 14,249

Summary of Significant Accounting Policies, Prepaid Expenses and Other (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Prepaid Expenses and Other [Abstract]
Deferred charges	$ 11,748	$ 14,266
Prepaid income tax	9,333	2,784
Prepaid inventory and import costs	3,540	6,087
Prepaid rent, insurance and other occupancy costs	5,830	3,690
Prepaid promotion and event cost	2,395	4,382
Prepaid other taxes	8,768	9,333
Derivative financial instruments	9,156	557
Prepaid software license	17,463	17,041
Deposits	1,153	1,158
Other	18,430	17,608
Total prepaid expense and other	$ 87,816	$ 76,906

Summary of Significant Accounting Policies, Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2022
Buildings [Member]
Property and Equipment [Abstract]
Useful life	39 years
Furniture and Fixtures [Member] \| Minimum [Member]
Property and Equipment [Abstract]
Useful life	5 years
Furniture and Fixtures [Member] \| Maximum [Member]
Property and Equipment [Abstract]
Useful life	7 years
Computers and Equipment [Member] \| Minimum [Member]
Property and Equipment [Abstract]
Useful life	3 years
Computers and Equipment [Member] \| Maximum [Member]
Property and Equipment [Abstract]
Useful life	5 years
Leasehold Improvements [Member]
Property and Equipment [Abstract]
Useful life	Shorter of estimated useful life or lease term
Scanners [Member]
Property and Equipment [Abstract]
Useful life	3 years
Vehicles [Member] \| Minimum [Member]
Property and Equipment [Abstract]
Useful life	3 years
Vehicles [Member] \| Maximum [Member]
Property and Equipment [Abstract]
Useful life	5 years

Summary of Significant Accounting Policies, Goodwill and Other Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2022
Goodwill and Other Intangible Assets [Abstract]
Impairment of goodwill		$ 0.0		$ 0.0
Impairment of other intangible assets		$ 1.7
Manufacturing Reporting Unit [Member]
Goodwill and Other Intangible Assets [Abstract]
Percentage of fair value in excess of carrying amount					8.00%
Grow Tech Segment [Member]
Goodwill and Other Intangible Assets [Abstract]
Impairment of goodwill			$ 9.2
Grow Tech Segment [Member] \| Restructuring and Impairment Expenses [Member]
Goodwill and Other Intangible Assets [Abstract]
Impairment of goodwill and intangibles	$ 18.2

Summary of Significant Accounting Policies, Other Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Other Assets [Abstract]
Deferred taxes	$ 89,770	$ 26,483
Deposits for noncancelable operating leases	13,872	17,121
Cash surrender value for life insurance policies	40,055	49,851
Right-of-use assets, Financing, net	14,259	6,477
Derivative financial instruments	10,582	6,033
Long-term Investments	39,493	35,868
Other	36,398	33,627
Total other assets	$ 244,429	$ 175,460
Right-of-use assets, Financing, net Statement of Financial Position [Extensible Enumeration]	Total other assets	Total other assets

Summary of Significant Accounting Policies, Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Accrued Expenses [Abstract]
Accrued sales force commissions and other payments	$ 95,686	$ 139,793
Accrued other taxes	21,822	31,135
Accrued payroll and other employee expenses	37,650	53,641
Accrued payable to vendors	29,569	45,347
Short-term operating lease liability	29,376	33,427
Accrued royalties	845	1,095
Sales return reserve	3,359	3,513
Deferred revenue	27,053	33,139
Other	34,920	31,111
Total accrued expenses	$ 280,280	$ 372,201
Short-term operating lease liability, Statement of Financial Position [Extensible List]	Total accrued expenses	Total accrued expenses

Summary of Significant Accounting Policies, Other Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Other Liabilities [Abstract]
Deferred tax liabilities	$ 439	$ 2,385
Reserve for other tax liabilities	35,532	21,774
Liability for deferred compensation plan	44,427	54,213
Contingent consideration	6,364	10,341
Finance lease liabilities	12,140	5,318
Asset retirement obligation	5,978	5,408
Other	5,545	7,035
Total other liabilities	$ 110,425	$ 106,474
Finance lease liabilities, Statement of Financial Position [Extensible Enumeration]	Total other liabilities	Total other liabilities

Summary of Significant Accounting Policies, Revenue Recognition (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue Recognition [Abstract]
Sales returns	$ 31.6	$ 52.1	$ 49.5
Allowance for Product Returns [Member]
Revenue Recognition [Abstract]
Accrued reserve	$ 3.4	$ 3.5

Summary of Significant Accounting Policies, Contract Liabilities - Customer Loyalty Programs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Contract Liabilities - Customer Loyalty Programs [Abstract]
Contract liabilities for customer loyalty programs	$ 18.7	$ 22.0
Contract liabilities, increase (decrease) to revenue	$ 3.3	$ (3.8)	$ (5.7)

Summary of Significant Accounting Policies, Advertising Expenses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
General and Administrative Expenses [Member]
Advertising Expenses [Abstract]
Advertising costs incurred	$ 14.5	$ 15.5	$ 14.7

Summary of Significant Accounting Policies, Research and Development (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Research and Development [Abstract]
Research and development expense	$ 23.3	$ 27.2	$ 23.3

Summary of Significant Accounting Policies, Uncertain Tax Positions (Details) - Multiple Foreign and Domestic Authorities [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of Unrecognized Tax Benefits [Roll Forward]
Gross balance at beginning of year	$ 15,090	$ 17,620	$ 13,507
Increases related to prior year tax positions	6,768	4,146	2,958
Increases related to current year tax positions	5,485	1,794	3,302
Settlements	(2,590)	(5,494)	(1,091)
Decreases due to lapse of statutes of limitations	(95)	(2,409)	(1,377)
Currency adjustments	(1,559)	(567)
Currency adjustments			321
Gross balance at end of year	23,099	15,090	17,620
Uncertain Tax Positions [Abstract]
Unrecognized tax benefits that would impact effective tax rate	23,100	15,100
Interest and penalties expenses	5,700	1,600	1,500
Accrued interest and penalties	$ 12,400	$ 6,700	$ 5,100
Minimum [Member]
Uncertain Tax Positions [Abstract]
Statute of limitations related to income tax examinations	3 years
Uncertain Tax Positions [Abstract]
Estimated increase in gross unrecognized tax benefits within next 12 months	$ 2,000
Maximum [Member]
Uncertain Tax Positions [Abstract]
Statute of limitations related to income tax examinations	10 years
Uncertain Tax Positions [Abstract]
Estimated increase in gross unrecognized tax benefits within next 12 months	$ 3,000

Summary of Significant Accounting Policies, Foreign Currency Translation (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Foreign Currency Translation [Abstract]
Cumulative translation adjustment related to foreign currency adjustment	$ (102.0)	$ (79.1)	$ (65.6)
Cumulative translation adjustment related to foreign currency adjustment, tax	$ 8.1	$ 7.5	$ 7.1

Summary of Significant Accounting Policies, Classification of a Highly Inflationary Economy (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Argentina [Member] \| Net Sales [Member] \| Geographic Concentration Risk [Member] \| Maximum [Member]
Operations in Argentina [Abstract]
Concentration percentage	2.00%	2.00%	2.00%

Summary of Significant Accounting Policies, Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Fair Value of Financial Instruments [Abstract]
Fair value of debt	$ 405.0	$ 377.5

Summary of Significant Accounting Policies, Stock-Based Compensation (Details) - General and Administrative Expenses [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Stock-Based Compensation [Abstract]
Compensation expense related to equity compensation plans	$ 12.4	$ 23.2	$ 24.1
Reversal of compensation expense for certain performance based awards no longer expected to vest	$ 1.3	$ 0.0	$ 0.0

Property and Equipment (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Property and Equipment [Abstract]

Property and equipment

$ 786,992

$ 819,214

Less: accumulated depreciation

(342,186)

(365,540)

Property and equipment, net

444,806

453,674

Depreciation expense

61,000

62,900

$ 62,500

Impairment of fixed assets

8,200

13,700

Land [Member]

Property and Equipment [Abstract]

Property and equipment

42,931

45,027

Buildings [Member]

Property and Equipment [Abstract]

Property and equipment

274,049

281,192

Construction in Progress [Member]

Property and Equipment [Abstract]

Property and equipment

^[1]

64,566

44,021

Furniture and Fixtures [Member]

Property and Equipment [Abstract]

Property and equipment

136,835

147,786

Computers and Equipment [Member]

Property and Equipment [Abstract]

Property and equipment

145,934

162,746

Leasehold Improvements [Member]

Property and Equipment [Abstract]

Property and equipment

114,633

129,675

Scanners [Member]

Property and Equipment [Abstract]

Property and equipment

6,438

6,746

Vehicles [Member]

Property and Equipment [Abstract]

Property and equipment

1,606

2,021

Internal-Use Software Development Costs [Member]

Property and Equipment [Abstract]

Property and equipment

$ 20,500

$ 11,000

[1]	Construction in progress includes $20.5 million and $11.0 million as of December 31, 2022 and 2021, respectively, of eligible capitalized internal-use software development costs which will be reclassified to computers and equipment when placed into service.

Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
Goodwill (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill [Abstract]
Goodwill	$ 206,432	$ 206,432
Impairment charges	0		$ 0
Americas [Member]
Goodwill [Abstract]
Goodwill	9,449	9,449
Mainland China [Member]
Goodwill [Abstract]
Goodwill	32,179	32,179
Southeast Asia/Pacific [Member]
Goodwill [Abstract]
Goodwill	18,537	18,537
South Korea [Member]
Goodwill [Abstract]
Goodwill	29,261	29,261
Japan [Member]
Goodwill [Abstract]
Goodwill	16,019	16,019
EMEA [Member]
Goodwill [Abstract]
Goodwill	2,875	2,875
Hong Kong/Taiwan [Member]
Goodwill [Abstract]
Goodwill	6,634	6,634
Manufacturing [Member]
Goodwill [Abstract]
Goodwill	78,875	78,875
Rhyz Other [Member]
Goodwill [Abstract]
Goodwill	$ 12,603	12,603
Grow Tech [Member]
Goodwill [Abstract]
Impairment charges		$ 9,200

Other Intangible Assets, Indefinite Life Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Trademarks and Trade Names [Member]
Indefinite Life Intangible Assets [Abstract]
Indefinite life intangible assets	$ 24,599	$ 24,599

Other Intangible Assets, Finite Life Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite Life Intangible Assets [Abstract]
Gross carrying amount	$ 152,300	$ 156,320
Accumulated amortization	$ 110,198	103,928
Weighted-average amortization period	13 years
Amortization expense	$ 9,700	11,700	$ 9,800
Scanner Technology [Member]
Finite Life Intangible Assets [Abstract]
Gross carrying amount	40,716	40,716
Accumulated amortization	$ 40,716	40,716
Weighted-average amortization period	18 years
Developed Technology [Member]
Finite Life Intangible Assets [Abstract]
Gross carrying amount	$ 43,841	43,841
Accumulated amortization	$ 27,365	24,697
Weighted-average amortization period	14 years
Sales Force Network [Member]
Finite Life Intangible Assets [Abstract]
Gross carrying amount	$ 11,598	11,598
Accumulated amortization	$ 11,598	11,598
Weighted-average amortization period	15 years
Trademarks [Member]
Finite Life Intangible Assets [Abstract]
Gross carrying amount	$ 7,860	8,989
Accumulated amortization	$ 4,200	3,827
Weighted-average amortization period	9 years
Other [Member]
Finite Life Intangible Assets [Abstract]
Gross carrying amount	$ 48,285	51,176
Accumulated amortization	$ 26,319	$ 23,090
Weighted-average amortization period	8 years

Other Intangible Assets, Annual Estimated Future Amortization Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Annual Estimated Future Amortization Expense [Abstract]
2023	$ 9,595
2024	9,108
2025	7,826
2026	6,222
2027	4,373
Impairment Charges [Abstract]
Impairment of other intangible assets	1,700
Exit Grow Tech Segment [Member]
Impairment Charges [Abstract]
Impairment charge related to indefinite lived intangible assets		$ 3,800
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income [Extensible Enumeration]		Restructuring and impairment expenses
Impairment of other intangible assets		$ 5,200
Impairment, Intangible Asset, Finite-Lived, Statement of Income [Extensible Enumeration]		Restructuring and impairment expenses
2022 Strategic Restructuring Plan [Member]
Impairment Charges [Abstract]
Impairment of other intangible assets	$ 1,700
Impairment, Intangible Asset, Finite-Lived, Statement of Income [Extensible Enumeration]	Restructuring and impairment expenses

Long-Term Debt, 2018 Credit Agreement (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Apr. 18, 2018
2018 Credit Agreement [Member] \| Maximum [Member]
Long-Term Debt [Abstract]
Consolidated leverage ratio	2.25
2018 Credit Agreement [Member] \| Minimum [Member]
Long-Term Debt [Abstract]
Consolidated interest coverage ratio	3
2018 Term Loan Facility [Member]
Long-Term Debt [Abstract]
Original principal amount	$ 400.0	$ 400.0
Term of loan	5 years
2018 Term Loan Facility [Member] \| First Year [Member]
Long-Term Debt [Abstract]
Annual amortization percentage	5.00%
2018 Term Loan Facility [Member] \| Second Year [Member]
Long-Term Debt [Abstract]
Annual amortization percentage	5.00%
2018 Term Loan Facility [Member] \| Third Year [Member]
Long-Term Debt [Abstract]
Annual amortization percentage	7.50%
2018 Term Loan Facility [Member] \| Fourth Year [Member]
Long-Term Debt [Abstract]
Annual amortization percentage	7.50%
2018 Term Loan Facility [Member] \| Fifth Year [Member]
Long-Term Debt [Abstract]
Annual amortization percentage	10.00%
2018 Revolving Credit Facility [Member]
Long-Term Debt [Abstract]
Borrowing capacity		$ 350.0
Term of loan	5 years

Long- Term Debt, Credit Agreement (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Jun. 14, 2022
Credit Agreement [Member]
Debt [Abstract]
Percentage of capital stock of certain foreign subsidiaries pledged as collateral	65.00%
Credit Agreement [Member] \| Minimum [Member]
Debt [Abstract]
Commitment fee percentage payable on unused portion	0.175%
Consolidated interest coverage ratio	3
Credit Agreement [Member] \| Maximum [Member]
Debt [Abstract]
Commitment fee percentage payable on unused portion	0.30%
Consolidated leverage ratio	2.75
Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 400.0	$ 400.0
Term of loan	5 years
Term Loan Facility [Member] \| First Year [Member]
Debt [Abstract]
Annual amortization percentage	2.50%
Term Loan Facility [Member] \| Second Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] \| Third Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] \| Fourth Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] \| Fifth Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity		$ 500.0
Term of loan	5 years

Long-Term Debt, Debt Facilities (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2022

Jun. 14, 2022

Dec. 31, 2021

Apr. 18, 2018

Long-term Debt [Abstract]

Balance

^[1]

$ 395,000

Current portion of long-term debt

25,000

$ 107,500

Unamortized debt issuance costs

2,500

2018 Credit Agreement [Member]

Long-term Debt [Abstract]

Unamortized debt issuance costs

1,200

2018 Credit Agreement Term Loan Facility [Member]

Long-term Debt [Abstract]

Original principal amount

400,000

$ 400,000

Balance

^[2],[3]

$ 0

307,500

Repayment terms

Principal amount was paid in full during June 2022.

Term of loan

5 years

Current portion of long-term debt

37,500

2018 Credit Agreement Revolving Credit Facility [Member]

Long-term Debt [Abstract]

Balance

^[2],[3]

$ 0

70,000

Repayment terms

Principal amount was paid in full during June 2022 and credit line was closed.

Term of loan

5 years

Credit Agreement [Member]

Long-term Debt [Abstract]

Unamortized debt issuance costs

$ 2,500

Credit Agreement Term Loan Facility [Member]

Long-term Debt [Abstract]

Original principal amount

400,000

$ 400,000

Balance

^[2],[3]

$ 395,000

Interest rate

Variable 30 day: 6.17%

Interest rate

6.17%

Term of variable rate

30 days

Repayment terms

21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end

Percentage of principal payable in installments

21.00%

Term of loan

5 years

Current portion of long-term debt

$ 15,000

Credit Agreement Revolving Credit Facility [Member]

Long-term Debt [Abstract]

Balance

^[2],[3]

$ 10,000

$ 0

Interest rate

Variable 30 day: 6.17%

Interest rate

6.17%

Term of variable rate

30 days

Repayment terms

Revolving line of credit expires June 14, 2027.

Term of loan

5 years

[1]	The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $2.5 million, which is not reflected in this table.
[2]	As of December 31, 2022 and 2021, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $15.0 million and $37.5 million, respectively, of the balance of its term loan under the Credit Agreement and 2018 Credit Agreement.
[3]	The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.5 million and $1.2 million as of December 31, 2022 and 2021, respectively, related to the Credit Agreement and 2018 Credit Agreement, which are not reflected in this table.

Long-Term Debt, Maturities of Long-Term Debt (Details)
$ in Thousands

Dec. 31, 2022

USD ($)

Maturities of Long-term Debt [Abstract]

$ 15,000

20,000

20,000

20,000

320,000

395,000

^[1]

Unamortized debt issuance costs

$ 2,500

[1]	The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $2.5 million, which is not reflected in this table.

Leases (Details) - USD ($) $ in Thousands	12 Months Ended
Leases (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Weighted average remaining lease term for operating leases	8 years 9 months 18 days
Weighted average remaining lease term for finance lease	4 years 7 months 6 days
Weighted average discount rate for operating leases	3.30%
Weighted average discount rate for finance lease	3.50%
Operating Lease Expense [Abstract]
Operating lease cost	$ 39,682	$ 48,447	$ 51,828
Variable lease cost	6,061	5,734	4,366
Short-term lease cost	210	592	1,056
Sublease income	0	(5,663)	(5,052)
Finance Lease Expense [Abstract]
Amortization of right-of-use assets	2,371	2,398	1,023
Interest on lease liabilities	268	319	154
Total lease expense	48,592	51,827	53,375
Supplemental Cash Flow Information Related to Leases [Abstract]
Operating cash outflow from operating leases	37,174	51,570	56,395
Operating cash outflow from finance leases	243	322	138
Financing cash outflow from finance leases	1,919	1,871	709
Right-of-use assets obtained in exchange for operating lease obligations	34,026	25,427	82,662
Right-of-use assets obtained in exchange for finance lease obligations	9,797	$ 74	$ 9,206
Maturities of Operating Lease Liabilities [Abstract]
2023	26,086
2024	18,808
2025	13,338
2026	8,692
2027	7,690
Thereafter	42,385
Total	116,999
Less: Finance charges	15,542
Total principal liability	101,457
Maturities of Finance Lease Liabilities [Abstract]
2023	3,836
2024	3,428
2025	3,371
2026	3,277
2027	2,933
Thereafter	0
Total	16,845
Less: Finance charges	1,362
Total principal liability	15,483
Additional lease liabilities not yet commenced	$ 5,500
Minimum [Member]
Leases [Abstract]
Remaining lease terms	1 year
Maximum [Member]
Leases [Abstract]
Remaining lease terms	22 years
Extension period for leases	20 years
Termination period for leases	1 year

Capital Stock, Authorized Capital Stock (Details)	12 Months Ended
Capital Stock, Authorized Capital Stock (Details)	Dec. 31, 2022 Vote $ / shares shares	Dec. 31, 2021 $ / shares shares
Capital Stock [Abstract]
Preferred stock, authorized (in shares)	25,000,000
Preferred stock, par value (in dollars per share) \| $ / shares	$ 0.001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, par value (in dollars per share) \| $ / shares	$ 0.001	$ 0.001
Preferred stock, shares outstanding (in shares)	0	0
Common Class A [Member]
Capital Stock [Abstract]
Common stock, shares authorized (in shares)	500,000,000
Common stock, par value (in dollars per share) \| $ / shares	$ 0.001
Number of votes per share \| Vote	1
Common Class B [Member]
Capital Stock [Abstract]
Common stock, shares authorized (in shares)	100,000,000
Common stock, par value (in dollars per share) \| $ / shares	$ 0.001
Common stock, shares outstanding (in shares)	0	0

Capital Stock, Weighted Average Shares Outstanding (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Weighted Average Shares Outstanding [Abstract]
Basic weighted-average common shares outstanding (in shares)	50,002	50,193	52,296
Effect of Dilutive Securities [Abstract]
Stock awards and options (in shares)	523	1,234	469
Diluted weighted-average common shares outstanding (in shares)	50,525	51,427	52,765
Stock Options [Member]
Weighted Average Shares Outstanding [Abstract]
Anti-dilutive shares excluded from calculation of diluted earnings per share (in shares)	100	100	400

Capital Stock, Dividends (Details) - USD ($) $ / shares in Units, $ in Thousands	2 Months Ended	3 Months Ended								12 Months Ended
	Feb. 15, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Dividends [Abstract]
Payment of cash dividends										$ 77,015	$ 76,272	$ 78,387
Dividend Declared 2022-Q1 [Member]
Dividends [Abstract]
Cash dividend paid (in dollars per share)					$ 0.385
Dividend Declared 2022-Q2 [Member]
Dividends [Abstract]
Cash dividend paid (in dollars per share)				$ 0.385
Dividend Declared 2022-Q3 [Member]
Dividends [Abstract]
Cash dividend paid (in dollars per share)			$ 0.385
Dividend Declared 2022-Q4 [Member]
Dividends [Abstract]
Cash dividend paid (in dollars per share)		$ 0.385
Dividend Declared 2021-Q1 [Member]
Dividends [Abstract]
Cash dividend paid (in dollars per share)									$ 0.38
Dividend Declared 2021-Q2 [Member]
Dividends [Abstract]
Cash dividend paid (in dollars per share)								$ 0.38
Dividend Declared 2021-Q3 [Member]
Dividends [Abstract]
Cash dividend paid (in dollars per share)							$ 0.38
Dividend Declared 2021-Q4 [Member]
Dividends [Abstract]
Cash dividend paid (in dollars per share)						$ 0.38
Dividend Declared 2023-Q1 [Member] \| Subsequent Event [Member]
Dividends [Abstract]
Dividend payable per share (in dollars per share)	$ 0.39
Dividend payable, date to be paid	Mar. 08, 2023
Dividend payable, date of record	Feb. 27, 2023

Capital Stock, Repurchases of Common Stock (Details) - USD ($) $ in Thousands, shares in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jul. 31, 2018
Repurchases of Common Stock [Abstract]
Class A common stock repurchased	$ 70,045	$ 80,420	$ 144,334
2018 Stock Repurchase Plan [Member]
Repurchases of Common Stock [Abstract]
Authorized amount				$ 500,000
Amount available for repurchases	175,400
Treasury Stock [Member]
Repurchases of Common Stock [Abstract]
Class A common stock repurchased	$ 70,045	$ 80,420	$ 144,334
Treasury Stock [Member] \| 2018 Stock Repurchase Plan [Member]
Repurchases of Common Stock [Abstract]
Class A common stock repurchased (in shares)	1.7	1.6	5.1
Class A common stock repurchased	$ 70,000	$ 80,400	$ 144,300

Stock-Based Compensation, Equity Incentive Plans (Details) - 2010 Omnibus Incentive Plan [Member] - shares shares in Millions				12 Months Ended
	Jun. 03, 2020	May 24, 2016	Jun. 03, 2013	Dec. 31, 2022	Apr. 30, 2010
Stock-Based Compensation [Abstract]
Number of shares authorized for issuance (in shares)					7.0
Number of additional shares authorized for issuance (in shares)	5.9	3.8	3.2
Stock Options [Member]
Stock-Based Compensation [Abstract]
Contractual term				7 years

Stock-Based Compensation, Stock Option Valuation Assumptions (Details) - Stock Options [Member] - $ / shares

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Fair Value Assumptions [Abstract]

Weighted-average grant date fair value of grants (in dollars per share)

$ 16.1

$ 8.59

Risk-free interest rate

^[1]

0.50%

1.40%

Dividend yield

^[2]

2.90%

Expected volatility

^[3]

49.50%

40.70%

Expected life in months

^[4]

56 months

59 months

Minimum [Member]

Fair Value Assumptions [Abstract]

Contractual life

7 years

Maximum [Member]

Fair Value Assumptions [Abstract]

Contractual life

10 years

[1]	The risk-free interest rate is based upon the rate on a zero-coupon U.S. Treasury bill, for periods within the contractual life of the option, in effect at the time of the grant.
[2]	The dividend yield is based on the average of historical stock prices and actual dividends paid.
[3]	Expected volatility is based on the historical volatility of the Company’s stock price, over a period similar to the expected life of the option.
[4]	The expected term of the option is based on the historical employee exercise behavior, the vesting terms of the respective option, and a contractual life of either seven or ten years.

Stock-Based Compensation, Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Number of Shares [Roll Forward]
Exercised (in shares)	(1,200,000)	(700,000)	(400,000)
Stock Options [Member]
Number of Shares [Roll Forward]
Outstanding at beginning of year (in shares)	2,758,300
Granted (in shares)	0
Exercised (in shares)	(680,500)
Forfeited/cancelled/expired (in shares)	(452,300)
Outstanding at end of year (in shares)	1,625,500	2,758,300
Exercisable at end of year (in shares)	1,122,500
Weighted-Average Exercise Price [Roll Forward]
Outstanding at beginning of year (in dollars per share)	$ 39.9
Granted (in dollars per share)	0
Exercised (in dollars per share)	31.65
Forfeited/cancelled/expired (in dollars per share)	50.95
Outstanding at end of year (in dollars per share)	40.04	$ 39.9
Exercisable at end of year (in dollars per share)	$ 39.2
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]
Outstanding options, weighted-average remaining contractual term	3 years 6 months 10 days
Outstanding options, aggregate intrinsic value	$ 10,349
Exercisable options, weighted-average remaining contractual term	2 years 11 months 15 days
Exercisable options, aggregate intrinsic value	$ 8,027
Service-Based Options [Member]
Number of Shares [Roll Forward]
Outstanding at beginning of year (in shares)	538,200
Granted (in shares)	0
Exercised (in shares)	(340,000)
Forfeited/cancelled/expired (in shares)	(34,300)
Outstanding at end of year (in shares)	163,900	538,200
Exercisable at end of year (in shares)	163,900
Weighted-Average Exercise Price [Roll Forward]
Outstanding at beginning of year (in dollars per share)	$ 35.89
Granted (in dollars per share)	0
Exercised (in dollars per share)	33.15
Forfeited/cancelled/expired (in dollars per share)	54.45
Outstanding at end of year (in dollars per share)	37.69	$ 35.89
Exercisable at end of year (in dollars per share)	$ 37.69
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]
Outstanding options, weighted-average remaining contractual term	4 months 6 days
Outstanding options, aggregate intrinsic value	$ 834
Exercisable options, weighted-average remaining contractual term	4 months 6 days
Exercisable options, aggregate intrinsic value	$ 834
Performance-Based Options [Member]
Number of Shares [Roll Forward]
Outstanding at beginning of year (in shares)	2,220,100
Granted (in shares)	0
Exercised (in shares)	(340,500)
Forfeited/cancelled/expired (in shares)	(418,000)
Outstanding at end of year (in shares)	1,461,600	2,220,100
Exercisable at end of year (in shares)	958,600
Weighted-Average Exercise Price [Roll Forward]
Outstanding at beginning of year (in dollars per share)	$ 40.87
Granted (in dollars per share)	0
Exercised (in dollars per share)	31.14
Forfeited/cancelled/expired (in dollars per share)	50.66
Outstanding at end of year (in dollars per share)	40.3	$ 40.87
Exercisable at end of year (in dollars per share)	$ 39.46
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]
Outstanding options, weighted-average remaining contractual term	3 years 10 months 20 days
Outstanding options, aggregate intrinsic value	$ 9,515
Exercisable options, weighted-average remaining contractual term	3 years 4 months 28 days
Exercisable options, aggregate intrinsic value	$ 7,193

Stock-Based Compensation, Stock Options Exercised (Details) - Stock Options [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Stock-Based Compensation [Abstract]
Cash proceeds from stock options exercised	$ 31,600	$ 14,435	$ 7,419
Tax benefit realized for stock options exercised	229	807
Tax expense realized for stock options exercised			(459)
Intrinsic value of stock options exercised	$ 15,505	$ 8,402	$ 5,232

Stock-Based Compensation, Nonvested Restricted and Performance Stock Awards (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Restricted Stock Awards [Member]
Number of Shares [Roll Forward]
Nonvested at beginning of year (in shares) \| shares	884,900
Granted (in shares) \| shares	587,100
Vested (in shares) \| shares	(326,600)
Forfeited (in shares) \| shares	(192,400)
Nonvested at end of year (in shares) \| shares	953,000
Weighted-Average Grant Date Fair Value [Abstract]
Nonvested, beginning balance (in dollars per share) \| $ / shares	$ 44.11
Granted (in dollars per share) \| $ / shares	46.04
Vested (in dollars per share) \| $ / shares	47.03
Forfeited (in dollars per share) \| $ / shares	44.01
Nonvested, Ending Balance (in dollars per share) \| $ / shares	$ 44.28
Performance Share Units [Member]
Number of Shares [Roll Forward]
Nonvested at beginning of year (in shares) \| shares	0
Granted (in shares) \| shares	192,700
Vested (in shares) \| shares	0
Forfeited (in shares) \| shares	(12,500)
Nonvested at end of year (in shares) \| shares	180,200
Weighted-Average Grant Date Fair Value [Abstract]
Nonvested, beginning balance (in dollars per share) \| $ / shares	$ 0
Granted (in dollars per share) \| $ / shares	44.39
Vested (in dollars per share) \| $ / shares	0
Forfeited (in dollars per share) \| $ / shares	44.39
Nonvested, Ending Balance (in dollars per share) \| $ / shares	$ 44.39

Stock-Based Compensation, Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Stock-Based Compensation Expense [Abstract]
Stock-based compensation expense (income)	$ 12,367	$ 23,194	$ 24,060
Stock Options [Member]
Unrecognized Stock-Based Compensation Expense [Abstract]
Unrecognized stock-based compensation expense	$ 100
Unrecognized stock-based compensation expense, period for recognition	1 month 6 days
Restricted Stock Awards [Member]
Unrecognized Stock-Based Compensation Expense [Abstract]
Unrecognized stock-based compensation expense	$ 29,600
Unrecognized stock-based compensation expense, period for recognition	2 years 7 months 6 days
Service-Based Options [Member]
Stock-Based Compensation Expense [Abstract]
Stock-based compensation expense (income)	$ 0	0	300
Service-Based Restricted Stock Units [Member]
Stock-Based Compensation Expense [Abstract]
Stock-based compensation expense (income)	14,300	15,400	13,900
Performance-Based Options [Member]
Stock-Based Compensation Expense [Abstract]
Stock-based compensation expense (income)	(2,000)	7,800	9,900
Performance Stock Units [Member]
Stock-Based Compensation Expense [Abstract]
Stock-based compensation expense (income)	$ 0	$ 0	$ 0

Fair Value and Equity Investments, Fair Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Contingent Consideration [Member]
Changes in Fair Value of Level 3 Contingent Consideration [Roll Forward]
Beginning balance	$ (10,341)	$ (3,125)
Additions from acquisitions	0	(8,702)
Changes in fair value of contingent consideration	3,977	1,486
Ending balance	(6,364)	(10,341)
Fair Value on a Recurring Basis [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	55,356	66,477
Derivative financial instruments asset	19,738	6,590
Life insurance contracts	40,055	49,851
Contingent consideration	(6,364)	(10,341)
Financial assets (liabilities)	108,785	112,577
Restricted current investments	4,900	5,200
Fair Value on a Recurring Basis [Member] \| Level 1 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	55,356	66,477
Derivative financial instruments asset	0	0
Life insurance contracts	0	0
Contingent consideration	0	0
Financial assets (liabilities)	55,356	66,477
Fair Value on a Recurring Basis [Member] \| Level 2 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Derivative financial instruments asset	19,738	6,590
Life insurance contracts	0	0
Contingent consideration	0	0
Financial assets (liabilities)	19,738	6,590
Fair Value on a Recurring Basis [Member] \| Level 3 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Derivative financial instruments asset	0	0
Life insurance contracts	40,055	49,851
Contingent consideration	(6,364)	(10,341)
Financial assets (liabilities)	33,691	39,510
Life Insurance Contracts [Member]
Changes in Fair Value of Level 3 Marketable Securities [Roll Forward]
Beginning balance	49,851	45,453
Actual return on plan assets	(9,180)	5,153
Purchases and issuances	0	6,261
Sales and settlements	(616)	(7,016)
Ending balance	$ 40,055	$ 49,851

Fair Value and Equity Investments, Equity Investments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Equity Investments [Abstract]
Upward fair value adjustments on equity securities	$ 0	$ 18,077	$ 0
Equity Securities [Member]
Equity Investments [Abstract]
Carrying amount of equity securities without readily determinable fair values	$ 28,100	28,100
Additional investment made		5,000
Equity Securities [Member] \| Other Income (Expense), Net [Member]
Equity Investments [Abstract]
Upward fair value adjustments on equity securities		$ 18,100

Income Taxes, Consolidated Income Before Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Consolidated Income Before Provision for Income Taxes [Abstract]
U.S.	$ 24,411	$ 45,371	$ 71,138
Foreign	64,559	187,088	185,094
Income before provision for income taxes	$ 88,970	$ 232,459	$ 256,232

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

Income Taxes, Current and Deferred Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current [Abstract]
Federal	$ 0	$ 0	$ 0
State	1,515	1,458	1,629
Foreign	34,117	77,393	77,079
Current income tax expense (benefit)	35,632	78,851	78,708
Deferred [Abstract]
Federal	(65,733)	3,705	(14,430)
State	(1,239)	(38)	(563)
Foreign	15,532	2,675	1,162
Deferred income tax expense (benefit)	(51,440)	6,342	(13,831)
Provision for income taxes	$ (15,808)	$ 85,193	$ 64,877

Income Taxes, Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Deferred Tax Assets [Abstract]
Inventory differences	$ 41,127	$ 5,859
Foreign tax credit and other foreign benefits	51,273	69,401
Stock-based compensation	5,981	9,392
Accrued expenses not deductible until paid	37,181	36,401
Foreign currency exchange	0	605
Net operating losses	12,773	9,479
Capitalized research and development	26,406	22,962
R&D credit carryforward	1,795	1,451
Other	242	34
Gross deferred tax assets	176,778	155,584
Deferred Tax Liabilities [Abstract]
Foreign currency exchange	3,225	0
Foreign withholding taxes	15,375	15,412
Intangibles step-up	4,446	4,446
Overhead allocation to inventory	3,504	3,373
Amortization of intangibles	21,211	21,936
Other	6,129	6,133
Gross deferred tax liabilities	53,890	51,300
Valuation allowance	(33,557)	(80,186)
Deferred taxes, net	89,331	$ 24,098
R&D Credit Carryforward [Member]
Tax Credit Carryforwards [Abstract]
Valuation allowance on tax credit carryforward	$ 1,800
R&D Credit Carryforward [Member] \| Minimum [Member]
Tax Credit Carryforwards [Abstract]
Expiration date	Dec. 31, 2036
R&D Credit Carryforward [Member] \| Maximum [Member]
Tax Credit Carryforwards [Abstract]
Expiration date	Dec. 31, 2041
Foreign Tax Credit [Member]
Operating Loss Carryforwards [Abstract]
Operating loss carryforwards	$ 35,400
Operating loss carryforwards subject to expiration	18,600
Operating loss carryforwards not subject to expiration	16,800
Operating loss carryforwards on which valuation allowance has been placed	34,800
Valuation allowance on operating loss carryforwards	12,700
Tax Credit Carryforwards [Abstract]
Valuation allowance on tax credit carryforward	$ 19,100
Foreign Tax Credit [Member] \| Minimum [Member]
Operating Loss Carryforwards [Abstract]
Expiration date	Dec. 31, 2023
Tax Credit Carryforwards [Abstract]
Expiration date	Dec. 31, 2028
Foreign Tax Credit [Member] \| Maximum [Member]
Operating Loss Carryforwards [Abstract]
Expiration date	Dec. 31, 2042
Tax Credit Carryforwards [Abstract]
Expiration date	Dec. 31, 2031

Income Taxes, Deferred Tax Asset Valuation Adjustments (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Valuation Allowance [Roll Forward]

Impact of change in capitalization policy for tax purposes under IRC Section 263A

$ (51,300)

Utilization of foreign tax credits

(18,100)

Valuation allowance release of foreign tax credits

(32,200)

Foreign tax credit carryforward due to disposal of Grow Tech segment

$ 11,900

Deferred Tax Asset Valuation Allowance [Member]

Valuation Allowance [Roll Forward]

Beginning balance

80,186

67,340

$ 77,042

Additions charged to cost and expenses

3,231

^[1]

12,674

^[2]

2,154

^[1]

Decreases

(50,315)

^[3]

^[4]

(12,100)

^[5]

Adjustments

^[6]

455

172

244

Ending balance

$ 33,557

$ 80,186

$ 67,340

[1]	Increase in valuation is due primarily to net operating losses in foreign markets.
[2]	Increase in valuation is primarily due to $11.9 million that was recorded on the foreign tax credit carryforward due to the disposal of the Company’s Grow Tech segment. The additional amount is due to net operating losses in foreign markets.
[3]	The decrease was due to utilization of $18.1 million of foreign tax credits and the valuation allowance release of $32.2 million foreign tax credits.
[4]	No decreases in 2021.
[5]	The decrease was due primarily to the utilization of foreign tax credits that had previously had a valuation allowance recorded against the asset.
[6]	Represents the net currency effects of translating valuation allowances at current rates of exchange.

Income Taxes, Deferred Taxes, Net of a Jurisdiction Basis (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Income Taxes [Abstract]
Net noncurrent deferred tax assets	$ 89,770	$ 26,483
Net noncurrent deferred tax liabilities	439	2,385
Deferred taxes, net	$ 89,331	$ 24,098

Income Taxes, Reconciliation of Statutory to Effective Tax Rate (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Effective Income Tax Rate Reconciliation [Abstract]
Income taxes at statutory rate	21.00%	21.00%	21.00%
Excess tax benefit from equity award	(0.12%)	(0.19%)	0.70%
Deferred compensation	2.18%	(0.46%)	(0.30%)
Executive salary limitation	2.06%	0.47%	0.04%
Non-U.S. income taxed at different rates	4.78%	6.06%	3.37%
Foreign withholding taxes	(0.73%)	4.71%	5.21%
Change in reserve for uncertain tax positions	17.69%	(0.06%)	1.98%
Valuation allowance recognized foreign tax credit & others	(56.17%)	5.12%	(4.59%)
Foreign-Derived Intangible Income (FDII)	(8.14%)	(0.87%)	(2.78%)
Other	(0.32%)	0.87%	0.69%
Effective income tax rate, continuing operations	(17.77%)	36.65%	25.32%
Cumulative amount of undistributed earnings of non-U.S. subsidiaries	$ 60.0
Incremental taxes if undistributed earnings on non-U.S. subsidiaries were repatriated	$ 6.0

Employee Benefit Plan (Details) - 401(k) Defined Contribution Plan [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
401(k) Defined Contribution Plan [Abstract]
Maximum percentage of compensation that can be deferred	100.00%
Minimum age to make contributions	18 years
Requisite service period	1 day
Percentage of employees' base pay matched by employer	4.00%	4.00%	4.00%
Vesting period for Company's matching contributions	2 years
Compensation expense	$ 3.8	$ 4.8	$ 4.4
Additional discretionary contribution by employer, maximum percentage of employees' base pay	10.00%
Additional discretionary contribution by employer, annual vesting percentage	20.00%
Vesting period for Company's additional discretionary contributions	5 years

Deferred Compensation Plan (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Deferred Compensation Plan [Abstract]
Percentage of participant's base salary contributed	5.00%	10.00%
Percentage of Company contributions that vest after ten years of service	50.00%
Number of years of service to qualify for 50% vesting in Company contributions	10 years
Percentage of Company contributions that vest annually thereafter	5.00%
Minimum age for participant's unvested company contributions to fully vest	60 years
Percentage of Company contributions that vest after five years of service	20.00%
Vesting period	5 years
Participant's vesting percentage	100.00%
Compensation expense	$ 2,300	$ 4,000	$ 2,300
Long-term deferred compensation liability	44,427	54,213
Investment in Rabbi Trust	$ 40,100	$ 49,900
Maximum [Member]
Deferred Compensation Plan [Abstract]
Percentage of participant's salary that can be deferred	80.00%
Percentage of participant's bonus or director fees that can be deferred	100.00%
Minimum [Member]
Deferred Compensation Plan [Abstract]
Number of years of service required for accelerated vesting above specified compensation level	10 years

Derivative Financial Instruments, Fair Value of Derivative Instruments on the Balance Sheet (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) Derivatives	Dec. 31, 2021 USD ($)
Derivatives and Hedging Activities [Abstract]
Loss to be reclassified to interest expense during next twelve months	$ (9,200)
Number of outstanding derivatives held \| Derivatives	4
Notional amount	$ 200,000
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Prepaid Expenses and Other [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, asset	9,156	$ 557
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Other Assets [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, asset	$ 10,582	$ 6,033

Derivative Financial Instruments, Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Details) - Interest Rate Swaps [Member] - Designated as Hedging Instrument [Member] - Cash Flow Hedges [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Other Income (Expense), Net [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	$ 3,117	$ (157)	$ (24)
Other Comprehensive Income [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) recognized in OCI	$ 16,267	$ 5,391	$ 1,017

Segment Information, Revenue by Segment (Details)
$ in Thousands

12 Months Ended

Dec. 31, 2022

USD ($)

Segment

Dec. 31, 2021

USD ($)

Dec. 31, 2020

USD ($)

Segment Information [Abstract]

Number of reportable segments | Segment

Number of geographic segments | Segment

Number of Rhyz Investments segments | Segment

Revenue by Segment [Abstract]

Revenue

$ 2,225,659

$ 2,695,669

$ 2,581,934

Other [Member]

Revenue by Segment [Abstract]

Revenue

3,959

3,653

886

Operating Segment [Member] | Nu Skin [Member]

Revenue by Segment [Abstract]

Revenue

2,072,371

2,523,112

2,432,595

Operating Segment [Member] | Americas [Member]

Revenue by Segment [Abstract]

Revenue

508,537

547,755

453,022

Operating Segment [Member] | Mainland China [Member]

Revenue by Segment [Abstract]

Revenue

360,389

568,774

625,538

Operating Segment [Member] | Southeast Asia/Pacific [Member]

Revenue by Segment [Abstract]

Revenue

344,411

336,651

361,627

Operating Segment [Member] | South Korea [Member]

Revenue by Segment [Abstract]

Revenue

268,707

354,252

326,478

Operating Segment [Member] | Japan [Member]

Revenue by Segment [Abstract]

Revenue

224,896

266,216

273,681

Operating Segment [Member] | EMEA [Member]

Revenue by Segment [Abstract]

Revenue

204,275

283,200

230,246

Operating Segment [Member] | Hong Kong/Taiwan [Member]

Revenue by Segment [Abstract]

Revenue

157,197

162,611

161,117

Operating Segment [Member] | Rhyz Investments [Member]

Revenue by Segment [Abstract]

Revenue

153,288

172,557

149,339

Operating Segment [Member] | Manufacturing [Member]

Revenue by Segment [Abstract]

Revenue

^[1]

149,458

172,120

149,339

Operating Segment [Member] | Rhyz Other [Member]

Revenue by Segment [Abstract]

Revenue

3,830

437

Intersegment [Member] | Manufacturing [Member]

Revenue by Segment [Abstract]

Revenue

$ 69,200

$ 84,500

$ 39,400

[1]	The Manufacturing segment had $69.2 million, $84.5 million and $39.4 million of intersegment revenue for the years ended December 31, 2022, 2021 and 2020, respectively. Intersegment revenue is eliminated in the consolidated financial statements and in the table above.

Segment Information, Segment Contribution (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Contribution [Abstract]
Operating income	$ 110,847	$ 233,992	$ 257,564
Other income (expense)	(21,877)	(1,533)	(1,332)
Income before provision for income taxes	88,970	232,459	256,232
Operating Segment [Member]
Segment Contribution [Abstract]
Operating income	459,580	627,085	602,835
Operating Segment [Member] \| Nu Skin [Member]
Segment Contribution [Abstract]
Operating income	462,190	610,552	581,667
Operating Segment [Member] \| Americas [Member]
Segment Contribution [Abstract]
Operating income	110,522	116,265	86,386
Operating Segment [Member] \| Mainland China [Member]
Segment Contribution [Abstract]
Operating income	72,362	151,645	181,024
Operating Segment [Member] \| Southeast Asia/Pacific [Member]
Segment Contribution [Abstract]
Operating income	85,827	81,779	87,753
Operating Segment [Member] \| South Korea [Member]
Segment Contribution [Abstract]
Operating income	81,804	114,034	100,933
Operating Segment [Member] \| Japan [Member]
Segment Contribution [Abstract]
Operating income	54,976	67,511	68,027
Operating Segment [Member] \| EMEA [Member]
Segment Contribution [Abstract]
Operating income	21,446	41,988	24,078
Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Segment Contribution [Abstract]
Operating income	35,253	37,330	33,466
Operating Segment [Member] \| Rhyz Investments [Member]
Segment Contribution [Abstract]
Operating income	(2,610)	16,533	21,168
Operating Segment [Member] \| Manufacturing [Member]
Segment Contribution [Abstract]
Operating income	3,570	18,346	21,168
Operating Segment [Member] \| Rhyz Other [Member]
Segment Contribution [Abstract]
Operating income	(6,180)	(1,813)	0
Corporate and Other [Member]
Segment Contribution [Abstract]
Operating income	$ (348,733)	$ (393,093)	$ (345,271)

Segment Information, Depreciation and Amortization and Capital Expenditures (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Summarized Financial Information [Abstract]
Depreciation and amortization	$ 72,506	$ 76,320	$ 73,991
Capital expenditures	59,056	68,615	63,823
Operating Segments [Member] \| Nu Skin [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	21,492	24,594	23,135
Capital expenditures	17,061	29,452	29,752
Operating Segments [Member] \| Americas [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	591	871	984
Capital expenditures	204	714	1,061
Operating Segments [Member] \| Mainland China [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	12,177	13,345	11,056
Capital expenditures	10,692	24,382	19,363
Operating Segments [Member] \| Southeast Asia/Pacific [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,500	1,450	1,670
Capital expenditures	263	1,330	2,197
Operating Segments [Member] \| South Korea [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,616	3,279	3,620
Capital expenditures	727	854	1,420
Operating Segments [Member] \| Japan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,011	906	1,876
Capital expenditures	225	194	3,128
Operating Segments [Member] \| EMEA [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	854	1,106	1,017
Capital expenditures	1,612	1,242	1,875
Operating Segments [Member] \| Hong Kong/Taiwan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,743	3,637	2,912
Capital expenditures	3,338	736	708
Operating Segments [Member] \| Rhyz Investments [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	16,206	13,344	8,081
Capital expenditures	7,301	14,022	14,366
Operating Segments [Member] \| Manufacturing [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	13,838	11,765	8,081
Capital expenditures	7,301	14,022	14,366
Operating Segments [Member] \| Rhyz Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	2,368	1,579	0
Capital expenditures	0	0	0
Corporate and Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	34,808	38,382	42,775
Capital expenditures	$ 34,694	$ 25,141	$ 19,705

Segment Information, Revenue by Major Market (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) Market	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Segment Information [Abstract]
Number of major markets \| Market	4
Number of markets \| Market	45
Segment Contribution [Abstract]
Revenue	$ 2,225,659	$ 2,695,669	$ 2,581,934
Major Market [Member] \| United States [Member]
Segment Contribution [Abstract]
Revenue	537,081	540,253	425,155
Major Market [Member] \| Mainland China [Member]
Segment Contribution [Abstract]
Revenue	360,389	568,774	625,538
Major Market [Member] \| South Korea [Member]
Segment Contribution [Abstract]
Revenue	268,707	354,252	326,478
Major Market [Member] \| Japan [Member]
Segment Contribution [Abstract]
Revenue	224,896	266,216	273,681
Major Market [Member] \| All Others [Member]
Segment Contribution [Abstract]
Revenue	$ 834,586	$ 966,174	$ 931,082

Segment Information, Revenue by Product Line (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue by Product Line [Abstract]
Revenue	$ 2,225,659	$ 2,695,669	$ 2,581,934
Beauty [Member]
Revenue by Product Line [Abstract]
Revenue	1,069,714	1,442,659	1,491,803
Wellness [Member]
Revenue by Product Line [Abstract]
Revenue	992,338	1,062,549	922,553
Other [Member]
Revenue by Product Line [Abstract]
Revenue	$ 163,607	$ 190,461	$ 167,578

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Segment Information, Long-Lived Assets by Major Market (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	$ 557,799	$ 581,124	$ 632,670
Major Market [Member] \| United States [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	343,482	335,020	348,028
Major Market [Member] \| Mainland China [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	132,148	149,124	152,312
Major Market [Member] \| South Korea [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	30,867	25,364	39,104
Major Market [Member] \| Japan [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	18,011	23,929	31,085
Major Market [Member] \| All Others [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	$ 33,291	$ 47,687	$ 62,141

Other Income (Expense), Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Other Income (Expense), Net [Abstract]
Other income (expense), net	$ (21,877)	$ (1,533)	$ (1,332)
Interest expense	$ 13,500	$ 11,000	$ 13,100

Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Supplemental Cash Flow Information [Abstract]
Cash paid for interest	$ 14.5	$ 8.6	$ 11.2
Cash paid for income taxes	$ 42.1	$ 96.0	$ 56.2

Acquisitions (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
Acquisitions (Details) - USD ($) $ in Thousands	Apr. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Acquisitions [Abstract]
Purchase price, net of cash acquired		$ 0	$ 18,963	$ 14,949
Accrued liability		34,920	31,111
Fair Value of Assets Acquired [Abstract]
Goodwill		$ 206,432	$ 206,432
Useful life		13 years
Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Useful life		9 years
Mavely [Member]
Acquisitions [Abstract]
Percentage interest acquired	100.00%
Purchase price, net of cash acquired	$ 16,800
Cash acquired	400
Accrued liability	900
Incremental contingent consideration	24,000
Contingent consideration	8,700
Gross purchase price	29,400
Fair Value of Assets Acquired [Abstract]
Intangible assets	16,400
Cash	400
Accounts receivable	100
Deferred tax liability	3,500
Goodwill	12,600
Mavely [Member] \| Customer Relationships [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	2,000
Useful life		4 years
Mavely [Member] \| Technology [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	11,300
Useful life		8 years
Mavely [Member] \| Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	2,800
Useful life		8 years
Mavely [Member] \| Other Intangibles [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	$ 300
Useful life		3 years

Restructuring and Severance Charges, Exit Grow Tech Segment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restructuring [Abstract]
Non-cash impairment charges	$ 48,494	$ 51,870	$ 0
Impairment of goodwill	0		$ 0
Impairment of fixed assets	8,200	13,700
Accrued Expenses [Member]
Restructuring [Abstract]
Liability related to cash charges		20,000
Exit Grow Tech Segment [Member]
Restructuring [Abstract]
Non-cash impairment charges		38,500
Impairment of goodwill		9,200
Impairment of intangible assets		9,000
Impairment of fixed assets		13,700
Inventory write-off		6,600
Cash charges associated with restructuring		20,000
Employee severance		6,500
Other related restructuring charges	5,000	$ 13,500
Cash payments	20,000
Ending restructuring accrual	$ 5,000

Restructuring and Severance Charges, Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restructuring [Abstract]
Impairment of fixed assets	$ 8,200	$ 13,700
Impairment of other intangible assets	1,700
Restructuring expenses	48,494	$ 51,870	$ 0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member]
Restructuring [Abstract]
Severance charges	20,100
Lease termination cost	7,400
Other associated restructuring costs	5,200
Impairment of fixed assets	8,200
Accelerated depreciation	900
Impairment of other intangible assets	1,700
Cash payments	21,000
Ending restructuring accrual	11,700
Restructuring expenses	43,494
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Minimum [Member]
Restructuring [Abstract]
Estimated restructuring costs	50,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Maximum [Member]
Restructuring [Abstract]
Estimated restructuring costs	55,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Nu Skin [Member]
Restructuring [Abstract]
Restructuring expenses	23,516
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Americas [Member]
Restructuring [Abstract]
Restructuring expenses	1,687
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Mainland China [Member]
Restructuring [Abstract]
Restructuring expenses	13,181
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Southeast Asia/Pacific [Member]
Restructuring [Abstract]
Restructuring expenses	1,809
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| South Korea [Member]
Restructuring [Abstract]
Restructuring expenses	1,533
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Japan [Member]
Restructuring [Abstract]
Restructuring expenses	699
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| EMEA [Member]
Restructuring [Abstract]
Restructuring expenses	2,143
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Restructuring [Abstract]
Restructuring expenses	2,464
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Rhyz Investments [Member]
Restructuring [Abstract]
Restructuring expenses	401
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Manufacturing [Member]
Restructuring [Abstract]
Restructuring expenses	401
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Rhyz Other [Member]
Restructuring [Abstract]
Restructuring expenses	0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Corporate and Other [Member]
Restructuring [Abstract]
Restructuring expenses	19,577
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Severance and Lease Termination [Member] \| Minimum [Member]
Restructuring [Abstract]
Estimated restructuring costs	40,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Severance and Lease Termination [Member] \| Maximum [Member]
Restructuring [Abstract]
Estimated restructuring costs	45,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Impairment of Fixed Assets, Acceleration of Depreciation and Other Intangibles Related to Footprint Optimization [Member]
Restructuring [Abstract]
Estimated restructuring costs	$ 10,000